<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Perioperative glycaemic control for people with diabetes undergoing surgery - Bellon, F - 2023 | Cochrane Library</title> <meta content="Perioperative glycaemic control for people with diabetes undergoing surgery - Bellon, F - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007315.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Perioperative glycaemic control for people with diabetes undergoing surgery - Bellon, F - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007315.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007315.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Perioperative glycaemic control for people with diabetes undergoing surgery" name="citation_title"/> <meta content="Filip Bellon" name="citation_author"/> <meta content="Ivan Solà" name="citation_author"/> <meta content="CIBER Epidemiología y Salud Pública (CIBERESP)" name="citation_author_institution"/> <meta content="Gabriel Gimenez-Perez" name="citation_author"/> <meta content="Marta Hernández" name="citation_author"/> <meta content="Hospital Universitari Arnau de Vilanova, Institut de Recerca Biomèdica de Lleida (IRBLLEIDA)" name="citation_author_institution"/> <meta content="Maria-Inti Metzendorf" name="citation_author"/> <meta content="Medical Faculty of the Heinrich-Heine-University Düsseldorf" name="citation_author_institution"/> <meta content="Esther Rubinat&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="Didac Mauricio&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="didacmauricio@gmail.com" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD007315.pub3" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/08/01" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007315.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007315.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007315.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Blood Glucose [analysis]; *Cardiovascular Diseases; *Diabetes Mellitus, Type 2 [complications]; Glycemic Control; *Hypoglycemia [chemically induced]; Hypoglycemic Agents [therapeutic use]; Quality of Life; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007315.pub3&amp;doi=10.1002/14651858.CD007315.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="WcPhDegp";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007315\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007315\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007315\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007315\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","ru","th","ms","ja","hr","fa","id","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007315.pub3",title:"Perioperative glycaemic control for people with diabetes undergoing surgery",firstPublishedDate:"Aug 1, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Metabolic and Endocrine Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WcPhDegp&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007315.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007315.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007315.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007315.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007315.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007315.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;id&quot;,&quot;title&quot;:&quot;Saripati tinjauan sistematik&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007315.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007315.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007315.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007315.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6072 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007315.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-sec-0101"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-sec-0015"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-sec-0016"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-sec-0057"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-sec-0095"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/appendices#CD007315-sec-0108"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/supinfo/CD007315-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/supinfo/CD007315-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Perioperative glycaemic control for people with diabetes undergoing surgery</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/information#CD007315-cr-0004">Filip Bellon</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/information#CD007315-cr-0005">Ivan Solà</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/information#CD007315-cr-0006">Gabriel Gimenez-Perez</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/information#CD007315-cr-0007">Marta Hernández</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/information#CD007315-cr-0008">Maria-Inti Metzendorf</a></li> <li class="author custom-tooltip" title="These authors contributed equally to this work and should be considered as having joint senior authorship."><a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/information#CD007315-cr-0009">Esther Rubinat</a><sup>a</sup></li> <li class="author custom-tooltip" title="These authors contributed equally to this work and should be considered as having joint senior authorship."><a href="/cdsr/doi/10.1002/14651858.CD007315.pub3/information#CD007315-cr-0010"><i class="icon corresponding-author fa fa-envelope"></i>Didac Mauricio</a><sup>a</sup></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/information/en#CD007315-sec-0131">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 01 August 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007315.pub3">https://doi.org/10.1002/14651858.CD007315.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007315-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007315-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007315-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007315-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007315-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD007315-abs-0006">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007315-abs-0001" lang="en"> <section id="CD007315-sec-0001"> <h3 class="title" id="CD007315-sec-0001">Background</h3> <p>People with diabetes mellitus are at increased risk of postoperative complications. Data from randomised clinical trials and meta‐analyses point to a potential benefit of intensive glycaemic control, targeting near‐normal blood glucose, in people with hyperglycaemia (with and without diabetes mellitus) being submitted for surgical procedures. However, there is limited evidence concerning this question in people with diabetes mellitus undergoing surgery. </p> </section> <section id="CD007315-sec-0002"> <h3 class="title" id="CD007315-sec-0002">Objectives</h3> <p>To assess the effects of perioperative glycaemic control for people with diabetes undergoing surgery. </p> </section> <section id="CD007315-sec-0003"> <h3 class="title" id="CD007315-sec-0003">Search methods</h3> <p>For this update, we searched the databases CENTRAL, MEDLINE, LILACS, WHO ICTRP and ClinicalTrials.gov. The date of last search for all databases was 25 July 2022. We applied no language restrictions. </p> </section> <section id="CD007315-sec-0004"> <h3 class="title" id="CD007315-sec-0004">Selection criteria</h3> <p>We included randomised controlled clinical trials (RCTs) that prespecified different targets of perioperative glycaemic control for participants with diabetes (intensive versus conventional or standard care). </p> </section> <section id="CD007315-sec-0005"> <h3 class="title" id="CD007315-sec-0005">Data collection and analysis</h3> <p>Two authors independently extracted data and assessed the risk of bias. Our primary outcomes were all‐cause mortality, hypoglycaemic events and infectious complications. Secondary outcomes were cardiovascular events, renal failure, length of hospital and intensive care unit (ICU) stay, health‐related quality of life, socioeconomic effects, weight gain and mean blood glucose during the intervention. We summarised studies using meta‐analysis with a random‐effects model and calculated the risk ratio (RR) for dichotomous outcomes and the mean difference (MD) for continuous outcomes, using a 95% confidence interval (CI), or summarised outcomes with descriptive methods. We used the GRADE approach to evaluate the certainty of the evidence (CoE). </p> </section> <section id="CD007315-sec-0006"> <h3 class="title" id="CD007315-sec-0006">Main results</h3> <p>A total of eight additional studies were added to the 12 included studies in the previous review leading to 20 RCTs included in this update. A total of 2670 participants were randomised, of which 1320 were allocated to the intensive treatment group and 1350 to the comparison group. The duration of the intervention varied from during surgery to five days postoperative. No included trial had an overall low risk of bias. </p> <p>Intensive glycaemic control resulted in little or no difference in all‐cause mortality compared to conventional glycaemic control (130/1263 (10.3%) and 117/1288 (9.1%) events, RR 1.08, 95% CI 0.88 to 1.33; I<sup>2</sup> = 0%; 2551 participants, 18 studies; high CoE). </p> <p>Hypoglycaemic events, both severe and non‐severe, were mainly experienced in the intensive glycaemic control group. Intensive glycaemic control may slightly increase hypoglycaemic events compared to conventional glycaemic control (141/1184 (11.9%) and 41/1226 (3.3%) events, RR 3.36, 95% CI 1.69 to 6.67; I<sup>2</sup> = 64%; 2410 participants, 17 studies; low CoE), as well as those considered severe events (37/927 (4.0%) and 6/969 (0.6%), RR 4.73, 95% CI 2.12 to 10.55; I<sup>2</sup> = 0%; 1896 participants, 11 studies; low CoE). </p> <p>Intensive glycaemic control, compared to conventional glycaemic control, may result in little to no difference in the rate of infectious complications (160/1228 (13.0%) versus 224/1225 (18.2%) events, RR 0.75, 95% CI 0.55 to 1.04; P = 0.09; I<sup>2</sup> = 55%; 2453 participants, 18 studies; low CoE). </p> <p>Analysis of the predefined secondary outcomes revealed that intensive glycaemic control may result in a decrease in cardiovascular events compared to conventional glycaemic control (107/955 (11.2%) versus 125/978 (12.7%) events, RR 0.73, 95% CI 0.55 to 0.97; P = 0.03; I<sup>2</sup> = 44%; 1454 participants, 12 studies; low CoE). Further, intensive glycaemic control resulted in little or no difference in renal failure events compared to conventional glycaemic control (137/1029 (13.3%) and 158/1057 (14.9%), RR 0.92, 95% CI 0.69 to 1.22; P = 0.56; I<sup>2</sup> = 38%; 2086 participants, 14 studies; low CoE). </p> <p>We found little to no difference between intensive glycaemic control and conventional glycaemic control in length of ICU stay (MD ‐0.10 days, 95% CI ‐0.57 to 0.38; P = 0.69; I<sup>2</sup> = 69%; 1687 participants, 11 studies; low CoE), and length of hospital stay (MD ‐0.79 days, 95% CI ‐1.79 to 0.21; P = 0.12; I<sup>2</sup> = 77%; 1520 participants, 12 studies; very low CoE). Due to the differences within included studies, we did not pool data for the reduction of mean blood glucose. Intensive glycaemic control resulted in a mean lowering of blood glucose, ranging from 13.42 mg/dL to 91.30 mg/dL. One trial assessed health‐related quality of life in 12/37 participants in the intensive glycaemic control group, and 13/44 participants in the conventional glycaemic control group; no important difference was shown in the measured physical health composite score of the short‐form 12‐item health survey (SF‐12). One substudy reported a cost analysis of the population of an included study showing a higher total hospital cost in the conventional glycaemic control group, USD 42,052 (32,858 to 56,421) compared to the intensive glycaemic control group, USD 40,884 (31.216 to 49,992). It is important to point out that there is relevant heterogeneity between studies for several outcomes. </p> <p>We identified two ongoing trials. The results of these studies could add new information in future updates on this topic. </p> </section> <section id="CD007315-sec-0007"> <h3 class="title" id="CD007315-sec-0007">Authors' conclusions</h3> <p>High‐certainty evidence indicates that perioperative intensive glycaemic control in people with diabetes undergoing surgery does not reduce all‐cause mortality compared to conventional glycaemic control. There is low‐certainty evidence that intensive glycaemic control may reduce the risk of cardiovascular events, but cause little to no difference to the risk of infectious complications after the intervention, while it may increase the risk of hypoglycaemia. There are no clear differences between the groups for the other outcomes. There are uncertainties among the intensive and conventional groups regarding the optimal glycaemic algorithm and target blood glucose concentrations. In addition, we found poor data on health‐related quality of life, socio‐economic effects and weight gain. It is also relevant to underline the heterogeneity among studies regarding clinical outcomes and methodological approaches. More studies are needed that consider these factors and provide a higher quality of evidence, especially for outcomes such as hypoglycaemia and infectious complications. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007315-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007315-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD007315-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD007315-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007315-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007315-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD007315-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/id#CD007315-abs-0013">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="full/ja#CD007315-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD007315-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD007315-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD007315-abs-0007">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD007315-abs-0004">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007315-abs-0002" lang="en"> <h3>What are the effects of intensive control of blood sugar before, during and after surgery in people with diabetes? </h3> <p><b>Key messages</b> </p> <p>‐ Intensive blood sugar control leads to lower levels, which may increase the risk of 'hypoglycaemia' (low blood sugar levels below what is healthy). </p> <p>‐ Intensive control does not reduce mortality. Moreover, it may not reduce the risk of infections or kidney problems, or time in the hospital or intensive care unit. However, intensive control may reduce the risk of cardiovascular problems. </p> <p>‐ More studies are needed to understand the effect of this intervention across different types of surgeries. </p> <p><b>What is already known?</b> </p> <p>The perioperative period is the time surrounding an individual's surgical procedure, involving ward admission, anaesthesia and recovery after surgery, covering the preoperative (before operation), intraoperative (during operation) and postoperative (after operation) phases of surgery. People with diabetes mellitus are at more risk of complications after surgery than the general population. Diabetes is a well‐known risk factor for complications after surgery, causing more extended hospital stays, higher healthcare resource utilisation and even more deaths. One of the most important medical complications is the increased risk of infections in the period around a surgical procedure. However, it is still unclear whether targeting more intensive blood glucose control (glycaemic control) during the perioperative period is better than targeting conventional blood glucose to reduce surgical risk in people with diabetes mellitus. </p> <p><b>What did we want to find out?</b> </p> <p>The results of the previous review were not clear on how to handle blood glucose control during surgery in people with diabetes. Therefore, we have performed an update to obtain the most recent scientific evidence available on glucose management in people undergoing surgery. </p> <p><b>What did we find?</b> </p> <p>We identified eight new studies that add to the previous 12 included in the last review, so a total of 20 trials are now included in this review. All the trials evaluated intensive control of blood sugar. We included 1320 participants with diabetes randomised to perioperative intensive glucose control and 1350 participants with diabetes randomised to conventional or regular glucose control in our analyses. The trials were conducted on all continents. The mean duration of the intervention period varied from during surgery to five days. The mean age of the participants was 63 years. </p> <p><b>What were the main results of our review?</b> </p> <p>Despite lower blood sugar concentrations during the perioperative period, intensive glucose control may lead to little or no reduction in relevant postoperative outcomes such as risk of infection, kidney problems, and hospital and intensive care unit stay. Likewise, intensive glycaemic control results in little or no difference in all‐cause mortality. </p> <p>Compared with conventional glucose control, intensive glucose control may reduce the risk of cardiovascular problems. </p> <p>Intensive glucose control may slightly increase the risk of hypoglycaemia events, including serious ones. </p> <p><b>What are the limitations of the evidence?</b> </p> <p>We have high confidence in the results for mortality, but our confidence is low or very low for the other results. This is because of limitations in the studies, and imprecise and inconsistent results. </p> <p><b>How up‐to‐date is the evidence?</b> </p> <p>This evidence is current to 25 July 2022</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007315-sec-0101" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007315-sec-0101"></div> <h3 class="title" id="CD007315-sec-0102">Implications for practice</h3> <section id="CD007315-sec-0102"> <p>We analysed 20 randomised controlled trials addressing the effect of perioperative intensive glycaemic management compared to conventional glucose control in people with diabetes mellitus undergoing a surgical procedure. More stringent glycaemic control reduced mean blood glucose with a mean lowering of blood glucose effect ranging from 13.42 mg/dL to 91.30 mg/dL. There is high‐certainty evidence that more stringent perioperative glycaemic control results in little or no difference in overall mortality in people with diabetes undergoing surgery. However, low‐certainty evidence indicates that people managed with more stringent perioperative glucose‐lowering regimens are at a slightly increased risk of developing hypoglycaemic events, including a slightly increased risk of severe hypoglycaemic events. Additionally, low‐certainty evidence indicates that people undergoing more stringent glycaemic perioperative management may have a reduced risk of cardiovascular events. No meaningful differences in length of hospital or intensive care unit stay were found, and there were no apparent differences in the other outcomes of perioperative intensive compared to conventional blood glucose control regimens. Only one study provided data on health‐related quality of life in a small number of individuals, for which no difference was noted. Regarding the socioeconomic effects, one study evaluated hospital cost and resource utilisation; this study did not reveal differences between intensive and conventional glucose control. </p> <p>It must be pointed out that the algorithms in the intervention and comparison arms varied substantially, including the target blood glucose concentrations. We could not analyse any results regarding the different types of surgical procedures. Apart from the heterogeneity in the design and delivery of the intervention, a relevant degree of heterogeneity was present regarding several study outcomes. Therefore, the interpretation of the findings of this review should consider the heterogeneity that affects the design and conduct of the studies, and their outcomes. </p> </section> <h3 class="title" id="CD007315-sec-0103">Implications for research</h3> <section id="CD007315-sec-0103"> <p>We are uncertain whether stringent perioperative glycaemic control in people with diabetes results in benefits for every type of surgical procedure. Furthermore, it is not well established which is the optimal blood glucose algorithm and glycaemic target range. Low‐certainty evidence exists for different clinically relevant outcomes, especially for hypoglycaemic events. Data on health‐related quality of life and socioeconomic effects are very scarce. Future studies should focus on these issues. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007315-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007315-sec-0008"></div> <div class="table" id="CD007315-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings: perioperative control for people with diabetes undergoing surgery</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="bottom"> <p><b>Perioperative glycaemic control for people with diabetes undergoing surgery</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Patients:</b> people with diabetes undergoing surgery </p> <p><b>Settings:</b> hospital </p> <p><b>Intervention:</b> intensive blood glucose control </p> <p><b>Comparison:</b> conventional blood glucose control </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comment</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with conventional glucose control <sup>a</sup> </b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with intensive glucose control</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> <p>(death from any cause)</p> <p>Follow‐up: from 28 days to 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>91 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>98 per 1000</b> (80 to 121) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.08</b> (0.88 to 1.33) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2551 (18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>high</b><sup>b,c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The pooled relative effect was based on 15 studies; 3 studies could not be included as they had zero events in both the intervention and control groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Severe hypoglycaemic episodes</b> </p> <p>(number of severe hypoglycaemic episodes)</p> <p>Follow‐up: from 28 days to 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>6 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 1000</b> (13 to 65) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 4.73</b> (2.12 to 10.55) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1896 (11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>c,e,f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The pooled relative effect was based on 8 studies; 3 studies could not be included as they had zero events in both the intervention and control groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Infectious complications</b> </p> <p>(infectious complication after surgery (e.g. pneumonia, urinary tract infection))</p> <p>Follow‐up: from 28 days to 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>183 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>137 per 1000</b> (101 to 190) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.75</b> (0.55 to 1.04) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2453 (18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>low</b><sup>c,g,h</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The pooled relative effect was based on 16 studies; 2 studies could not be included as they had zero events in both the intervention and control groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cardiovascular events</b> </p> <p>(incidents that may cause damage to the cardiovascular system)</p> <p>Follow‐up: from 28 days to 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>244 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>178 per 1000</b> (134 to 237) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.73</b> (0.55 to 0.97) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1454 (12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>low</b><sup>c,h,i</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The pooled relative effect was based on 11 studies; one study could not be included as it had zero events in both the intervention and control groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Renal failure</b> </p> <p>(number of individuals with an elevation of serum creatinine greater than 2 mg/dL or requiring dialysis) </p> <p>Follow‐up: from 28 days to 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>149 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>138 per 1000</b> (103 to 182) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.92</b> (0.69 to 1.22) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2086 (14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>low</b><sup>c,g,j</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Length of ICU stay</b> </p> <p>(days admitted to the ICU unit)</p> <p>Follow‐up: from 28 days to 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of ICU stay ranged across control groups from 1.2 to 7.4 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of ICU stay in the intervention groups was <b>0.1 days shorter</b> (0.57 days shorter to 0.38 days longer) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1687 (11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝</p> <p><b>low</b><sup>h,k</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Length of hospital stay</b> </p> <p>(days admitted to the hospital)</p> <p>Follow‐up: from 28 days to 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay ranged across control groups from 5.0 to 19.6 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay in the intervention groups was <b>0.79 days shorter</b> (1.79 days shorter to 0.21 days longer) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1520 (12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>very low</b><sup>h,k,l</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>CI:</b> confidence interval; <b>ICU:</b> intensive care unit; <b>MD:</b> mean difference; <b>RR:</b> risk ratio </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>GRADE Working Group quality of evidence grades</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Mean baseline risk from the included studies. </p> <p><sup>b</sup>Not downgraded for risk of bias: studies with an unclear risk of selection bias did not have major impact on certainty. A sensitivity analysis omitting these studies showed a similar effect estimate (RR 1.09, 95% CI 0.88 to 1.36). </p> <p><sup>c</sup>Optimal information sizes are estimated to assess the precision of the effect estimates according to a threshold of an anticipated 25% relative risk reduction. </p> <p><sup>d</sup>Not downgraded for imprecision: according to the control group event rate (0.1) and an anticipated 25% relative risk reduction, the optimal information size has been reached. </p> <p><sup>e</sup>Downgraded by one level due to the impact of risk of bias: the trial informing the outcome was open for participants and personnel, and many did not provide details on blinding of outcome assessment. </p> <p><sup>f</sup>Downgraded by one level for imprecision: optimal information size probably not met; with a 0.05 control group event rate and an anticipated 25% relative risk reduction, about 3500 participants would be required. </p> <p><sup>g</sup>Downgraded by one level for imprecision: optimal information size probably not met; with a 0.10 control group event rate and an anticipated 25% relative risk reduction, about 3000 participants would be required. </p> <p><sup>h</sup>Downgraded by one level due to risk of bias: all included studies were at an overall high risk of bias. </p> <p><sup>i</sup>Downgraded by one level for imprecision: optimal information size probably not met; with a 0.10 control group event rate and an anticipated 25% relative risk reduction, about 2000 participants would be required. </p> <p><sup>j</sup>Downgraded by one level for indirectness: heterogeneous definition of the outcome measure. </p> <p><sup>k</sup>Downgraded by one level for inconsistency: unexplained statistical heterogeneity within effect estimates from trials informing this outcome (I<sup>2</sup> = 69% for length of ICU stay, I<sup>2</sup> = 77% for length of hospital stay) with large differences in point estimates. </p> <p><sup>l</sup>Downgraded by one level for imprecision: lower 95% CI boundary includes the possibility of an important benefit. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007315-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007315-sec-0009"></div> <section id="CD007315-sec-0010"> <h3 class="title" id="CD007315-sec-0010">Description of the condition</h3> <p>Diabetes mellitus is a chronic disease that occurs when the pancreas does not secrete enough insulin or the body does not use insulin effectively, leading to hyperglycaemia. Different types of diabetes mellitus have been identified according to aetiological criteria that focus on the impact that various factors, such as genetics, insulin resistance, environmental markers and immune system inflammation, have on the progressive loss of the β‐cell mass and/or function. The most prevalent types of diabetes are type 1 and type 2, which are heterogeneous in their presentation and progression, and challenging to diagnose and treat. Treatment depends on the typology and must be individualised. Currently, non‐pharmacological actions (diet and exercise) are combined with oral hypoglycaemic agents (in type 2 diabetes) and/or insulin (<a href="./references#CD007315-bbs2-0074" title="American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes. Diabetes Care 1 January 2021;44 (supplement(Supplement_1):15-33. [DOI: https://doi.org/10.2337/dc21-S002]">ADA 2021</a>). </p> <p>The World Health Organization (WHO) considers diabetes mellitus to be a silent epidemic and estimates that more than 400 million people worldwide suffer from this condition, with a higher prevalence in low‐ and middle‐income countries. In 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes; 48% of deaths are premature (under the age of 70 years). Deaths due to diabetes are associated with complications arising from the impact of chronic hyperglycaemia at the micro‐ and macrovascular levels. Diabetes is a significant cause of blindness, kidney failure, heart attacks, stroke and lower limb amputation (<a href="./references#CD007315-bbs2-0128" title="World Health Organization. Improving diabetes outcomes for all, a hundred years on from the discovery of insulin: report of the Global Diabetes Summit. Vol. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization , 2021. [LICENCE: CC BY-NC-SA 3.0 IGO.]">WHO 2021</a>). </p> <p>People with diabetes mellitus are particularly vulnerable to surgical procedures due to the complex idiosyncrasy of the perioperative period. This period ranges from ward admission (preoperative), to anaesthesia and surgery (intraoperative), to recovery (postoperative). During the perioperative process, it is important to be aware of the interference of the disease in multiple organ systems and the well‐known potential complications, such as increased length of hospital stay, higher health care resource utilisation, and greater perioperative morbidity (particularly due to infection) and mortality (<a href="./references#CD007315-bbs2-0090" title="DraytonDJ , BirchRJ , D'Souza-FerrerC , AyresM , HowellSJ , AjjanRA . Diabetes mellitus and perioperative outcomes: a scoping review of the literature. British Journal of Anaesthesia May 2022;128(5):817-828. [DOI: doi: 10.1016/j.bja.2022.02.013] [PMID: 35300865]">Drayton 2022</a>). </p> <p>The increased risk of infection in the perioperative period is thought to be due to a combination of the long‐term effects of hyperglycaemia on blood vessels (occlusion) and neutrophil dysfunction due to immune‐mediated impairment. Hyperglycaemia also compromises phagocytosis, thus lowering the barriers to infection. Although the perioperative period is relatively short and many of the implications of hyperglycaemia are difficult to reverse, there is literature suggesting that improving glycaemic control enhances immune function and consequently reduces the risk of infection (<a href="./references#CD007315-bbs2-0075" title="ShojaniaKG , DuncanBW , McDonaldKM , WachterRM , Markowitz AJ. Making Health Care Safer: A Critical Analysis of Patient Safety Practices. AHRQ Publication No. 01-E058 edition. Rockville, MD: Agency for Healthcare Research and Quality, 2001.">AHRQ 2001</a>; <a href="./references#CD007315-bbs2-0123" title="SmileyDD , UmpierrezGE . Perioperative glucose control in the diabetic or nondiabetic patient. Southern Medical Journal2006;99(6):580-9; quiz 590-1. [MEDLINE: 16800413]">Smiley 2006</a>). </p> </section> <section id="CD007315-sec-0011"> <h3 class="title" id="CD007315-sec-0011">Description of the intervention</h3> <p>In the perioperative glycaemic management of people with diabetes, it is common practice to suspend or administer a minimal dose of hypoglycaemic drugs and start an intravenous infusion of glucose at a low rate while the individual is in fasting status. This infusion is prolonged until the person is able to start eating, at which point the usual drug regimen is restored. Often, a sliding‐scale insulin regimen or a schedule of regular, subcutaneous insulin dosages after capillary blood glucose measurements are also continued through the perioperative period. However, the use of a sliding scale may result in wide variations in serum glucose, questioning the rationale for this method (<a href="./references#CD007315-bbs2-0075" title="ShojaniaKG , DuncanBW , McDonaldKM , WachterRM , Markowitz AJ. Making Health Care Safer: A Critical Analysis of Patient Safety Practices. AHRQ Publication No. 01-E058 edition. Rockville, MD: Agency for Healthcare Research and Quality, 2001.">AHRQ 2001</a>). </p> <p>The importance of measuring the relationship between glycaemic control and the risk of complications before, during and after surgery for people with diabetes lies in the possibility of getting a better prediction of risk for individual people and of improving clinical surveillance during surgery. <a href="./references#CD007315-bbs2-0117" title="PomposelliJJ , Baxter JK 3rd, BabineauTJ , PomfretEA , DriscollDF , ForseRA , et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. Journal of Parenteral and Enteral Nutrition1998;22(2):77-81. [MEDLINE: 9527963]">Pomposelli 1998</a> studied the relationship between glycaemic perioperative control and postoperative nosocomial infection in 100 participants with diabetes undergoing elective surgery and found that a single blood glucose level greater than 220 mg/dL on the first postoperative day was a sensitive (87.5%) predictor of postoperative infection, with 2.7 times higher infection rates and, if minor infections were excluded, 5.7 times higher (serious) infection rates. <a href="./references#CD007315-bbs2-0091" title="FurnaryAP , ZerrKJ , GrunkemeierGL , StarrA . Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Annals of Thoracic Surgery1999;67(2):352-60; discussion 360-2. [MEDLINE: 10197653]">Furnary 1999</a> studied the relationship in 1499 individuals undergoing coronary artery bypass grafting and reported that a continuous insulin infusion protocol aimed at maintaining blood glucose within 150 mg/dL to 200 mg/dL was associated with a significant reduction in perioperative blood glucose levels, which led to a significant reduction in the incidence of deep sternal wounds. <a href="./references#CD007315-bbs2-0093" title="GoldenSH , Peart-VigilanceC , KaoWH , BrancatiFL . Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care1999;22(9):1408-14. [MEDLINE: 10480501]">Golden 1999</a> studied a cohort of 411 adults undergoing coronary artery surgery and found that, compared with participants with postoperative glucose levels within 121 mg/dL to 206 mg/dL, the risk of infection (defined as at least one of the following events 36 hours after surgery: pneumonia, urinary tract infection, wound infection or other infections with either positive culture or associated fever) was increased by 17% for those with blood glucose levels between 207 mg/dL and 229 mg/dL, by 78% in individuals with blood glucose levels between 253 mg/dL and 352 mg/dL, and by 86% for blood glucose levels between 230 mg/dL and 252 mg/dL. <a href="./references#CD007315-bbs2-0125" title="Greet Van den Berghe, Pieter Wouters, Frank Weekers, Charles Verwaest, Frans Bruyninckx, Miet Schetz, Dirk Vlasselaers, Patrick Ferdinande, Peter Lauwers, Roger Bouillon. Intensive Insulin Therapy in Critically Ill Patients. N Engl J Med 8 November 2001 ;345:1359-1367. [DOI: 10.1056/NEJMoa011300]">Van den Berghe 2001</a>studied whether the normalisation of blood glucose levels with insulin therapy improved the prognosis in a sample of 1548 critically ill participants receiving mechanical ventilation in a surgical intensive care unit (ICU) (783 and 765 assigned to conventional and intensive treatment, respectively). They reported that, at 12 months, intensive insulin therapy showed a significant mortality reduction from 8.0% with conventional treatment to 4.6%, even greater when analysing deaths due to multiple organ failure with a proven septic focus. Intensive insulin therapy also reduced overall in‐hospital mortality by 34%, bloodstream infections by 46%, acute renal failure requiring dialysis or haemofiltration by 41%, the median number of red cell transfusions by 50% and critical illness polyneuropathy by 44%. </p> <p>Controlled clinical trials studying the benefits of intensive glycaemic control versus conventional glycaemic control reported inconsistent findings. Thus, for example, <a href="./references#CD007315-bbs2-0125" title="Greet Van den Berghe, Pieter Wouters, Frank Weekers, Charles Verwaest, Frans Bruyninckx, Miet Schetz, Dirk Vlasselaers, Patrick Ferdinande, Peter Lauwers, Roger Bouillon. Intensive Insulin Therapy in Critically Ill Patients. N Engl J Med 8 November 2001 ;345:1359-1367. [DOI: 10.1056/NEJMoa011300]">Van den Berghe 2001</a>demonstrated significant benefits in mortality reduction associated with intensive insulin therapy. However, <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a> did not find significant benefits when analysing 371 adults undergoing on‐pump cardiac surgery. </p> <section id="CD007315-sec-0012"> <h4 class="title">Adverse effects of the intervention</h4> <p>The main adverse event that may be expected when introducing an intensive insulin regimen aimed at reaching normoglycaemia is hypoglycaemia. There is increasing evidence pointing to a potential link between hypoglycaemia and the risk of cardio/cerebrovascular events in people with diabetes (<a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0122" title="SeaquistER , AndersonJ , ChildsB , CryerP , Dagogo-JackS , FishL , HellerSR , RodriguezH , RosenzweigJ , Vigersky R. Hypoglycemia and diabetes: a report of a workgroup of the Diabetes Association and the Endocrine Society. Diabetes Care May 2013;36(5):1384-1395. [DOI: 10.2337/dc12-2480] [PMID: 23589542]">Seaquist 2013</a>). Actually, hypoglycaemia is clearly associated with an increased risk of cardiovascular events in people treated with glucose‐lowering medications that increase the risk of hypoglycaemia (mainly insulin and sulphonylureas); this risk has also been shown to be present in inpatients during hospitalisation periods (<a href="./references#CD007315-bbs2-0104" title="International Hypoglycaemia Study Group. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinology May 2019;7(5):385-296. [DOI: 10.1016/S2213-8587(18)30315-2] [PMID: 30926258]">International Hypoglycaemia Study Group 2019</a>). Although more research insight is needed to clarify the pathogenetic pathway through which hypoglycaemia may lead to cardiovascular disease events, several mechanisms may be involved, i.e. blood coagulation abnormalities, sympathoadrenal response (cardiac arrhythmia and haemodynamic changes), endothelial dysfunction and inflammatory response (<a href="./references#CD007315-bbs2-0104" title="International Hypoglycaemia Study Group. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinology May 2019;7(5):385-296. [DOI: 10.1016/S2213-8587(18)30315-2] [PMID: 30926258]">International Hypoglycaemia Study Group 2019</a>; <a href="./references#CD007315-bbs2-0122" title="SeaquistER , AndersonJ , ChildsB , CryerP , Dagogo-JackS , FishL , HellerSR , RodriguezH , RosenzweigJ , Vigersky R. Hypoglycemia and diabetes: a report of a workgroup of the Diabetes Association and the Endocrine Society. Diabetes Care May 2013;36(5):1384-1395. [DOI: 10.2337/dc12-2480] [PMID: 23589542]">Seaquist 2013</a>). </p> </section> </section> <section id="CD007315-sec-0013"> <h3 class="title" id="CD007315-sec-0013">How the intervention might work</h3> <p>Hyperglycaemia has been identified as an independent risk factor for perioperative surgical complications, including death (<a href="./references#CD007315-bbs2-0092" title="GandhiGY , NuttallGA , AbelMD , MullanyCJ , SchaffHV , WilliamsBA , et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clinic Proceedings2005;80(7):862-6. [MEDLINE: 16007890]">Gandhi 2005</a>). Hyperglycaemia is known to impact immune status, wound healing and vascular function. It is therefore conceivable that normalising an individual's blood glucose levels could reduce the morbidity and mortality associated with surgical interventions. </p> </section> <section id="CD007315-sec-0014"> <h3 class="title" id="CD007315-sec-0014">Why it is important to do this review</h3> <p>Currently, the available data point to a positive effect of improved glycaemic control on infections and other medical complications after surgical procedures. Although our previous systematic review demonstrated no clear differences for most outcomes when intensive perioperative glycaemic control was compared to conventional glycaemic control in participants with diabetes mellitus (<a href="./references#CD007315-bbs2-0131" title="BuchleitnerAM , Martínez-AlonsoM , HernándezM , SolàI , MauricioD . Perioperative glycaemic control for diabetic patients undergoing surgery. Cochrane Database of Systematic Reviews 29 February 2012, Issue 9. Art. No: CD007315. [DOI: 10.1002/14651858.CD007315.pub2]">Buchleitner 2012</a>), a post hoc analysis indicated that intensive glycaemic control was associated with a higher number of participants experiencing episodes of hypoglycaemia. Since the publication of the previous version of our review in 2012, several new eligible trials have been published. These events have thus triggered an update of this review. We have attempted to identify, appraise and synthesise all newly published research evidence relevant to assessing the effect of intensive glycaemic control on surgical adverse events and other outcomes, to update our previous findings in order to inform decision‐making and the development of guidelines for the perioperative management of people with diabetes undergoing major surgery. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007315-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007315-sec-0015"></div> <p>To assess the effects of perioperative glycaemic control for patients with diabetes undergoing surgery. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007315-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007315-sec-0016"></div> <section id="CD007315-sec-0017"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007315-sec-0018"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled clinical trials (RCTs).</p> </section> <section id="CD007315-sec-0019"> <h4 class="title">Types of participants</h4> <p>Participants of any age, sex or ethnicity with previously diagnosed type 1 or 2 diabetes mellitus and submitted to perioperative glycaemic control. We contacted the authors of trials reporting on people with and without diabetes and asked them for separate data on people with diabetes to include in this review. </p> <section id="CD007315-sec-0020"> <h5 class="title">Diagnostic criteria for diabetes mellitus</h5> <p>In order to be consistent with changes in the classification of, and diagnostic criteria for, diabetes mellitus over the years, the diagnosis should have been established using the standard criteria valid at the time of the trial commencing (for example, <a href="./references#CD007315-bbs2-0072" title="Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care2003;26(Suppl 1):S5-20.">ADA 2003</a>; <a href="./references#CD007315-bbs2-0073" title="American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care2010;33(Suppl 1):S62-9. [PMID: 20042775]">ADA 2010</a>; <a href="./references#CD007315-bbs2-0077" title="AlbertiKM , ZimmetPZ . Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine1998;15(7):539-53.">Alberti 1998</a>; <a href="./references#CD007315-bbs2-0127" title="World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. In: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999:1-59.">WHO 1999</a>). Ideally, the diagnostic criteria should have been described. We used the trial authors' definition of diabetes mellitus if necessary. We planned to subject diagnostic criteria to a sensitivity analysis. </p> </section> <section id="CD007315-sec-0021"> <h5 class="title">Definition of perioperative period</h5> <p>We considered the perioperative period as the time elapsed between admission, anaesthesia, surgery and recovery. </p> <p>Changes in diagnostic criteria may have produced significant variability in the clinical characteristics of the participants included as well as in the results obtained (which have been investigated through sensitivity analysis). </p> </section> </section> <section id="CD007315-sec-0022"> <h4 class="title">Types of interventions</h4> <p>We planned to investigate the following comparison of intervention versus control/comparator.</p> <section id="CD007315-sec-0023"> <h5 class="title">Intervention</h5> <p> <ul id="CD007315-list-0001"> <li> <p>Perioperative glycaemic control protocol proposed by the trial authors that involves a more intensive control than conventional care. </p> </li> </ul> </p> </section> <section id="CD007315-sec-0024"> <h5 class="title">Comparison</h5> <p> <ul id="CD007315-list-0002"> <li> <p>Perioperative glycaemic control protocol defined as standard or conventional care by the trial authors. </p> </li> </ul> </p> <p>Concomitant interventions had to be identical in both the intervention and comparator groups to establish fair comparisons. If a trial included multiple arms, we included any arm that met the inclusion criteria for this review. </p> </section> <section id="CD007315-sec-0025"> <h5 class="title">Minimum duration of intervention</h5> <p>The minimal clinically meaningful duration of the intervention ranged from just the duration of the surgical procedure up to 90 days of follow‐up. </p> </section> <section id="CD007315-sec-0026"> <h5 class="title">Minimum duration of follow‐up</h5> <p>The minimal duration of follow‐up was one day (24 hours) after the perioperative glycaemic intervention. </p> <p>We defined any follow‐up period going beyond the original time frame for the primary outcome measure as specified in the power calculation of the trials' protocol as an extended follow‐up period (also called an open‐label extension study) (<a href="./references#CD007315-bbs2-0083" title="BuchMH , AletahaD , EmeryP , SmolenJS . Reporting of long-term extension studies: lack of consistency calls for consensus. Annals of the Rheumatic Diseases2011;70(6):886-90.">Buch 2011</a>; <a href="./references#CD007315-bbs2-0114" title="MeganB , PickeringRM , WeatherallM . Design, objectives, execution and reporting of published open-label extension studies. Journal of Evaluation in Clinical Practice2012;18(2):209-15.">Megan 2012</a>). </p> </section> <section id="CD007315-sec-0027"> <h5 class="title">Summary of specific exclusion criteria</h5> <p>We excluded trials in the following categories:</p> <p> <ul id="CD007315-list-0003"> <li> <p>Participants with different morbidities that could influence the results or some kind of co‐medication. </p> </li> <li> <p>No separate data available in studies involving people with and without diabetes.</p> </li> <li> <p>Paediatric population.</p> </li> <li> <p>Emergency surgeries.</p> </li> <li> <p>People who had off‐pump cardiopulmonary bypass procedures.</p> </li> <li> <p>Study designs other than RCTs.</p> </li> </ul> </p> </section> </section> <section id="CD007315-sec-0028"> <h4 class="title">Types of outcome measures</h4> <p>We did not exclude a trial if it failed to report one or several of our primary or secondary outcome measures. If none of our primary or secondary outcomes were reported in the trial, we did not include the trial but provided some basic information in an additional table. </p> <p>We extracted the following outcomes, using the methods and time points specified below (<a href="./references#CD007315-bbs2-0110" title="LefebvreC , GlanvilleJ , BriscoeS , LittlewoodA , MarshallC , MetzendorfMI , et al, Cochrane Information Retrieval Methods Group. Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.">Lefebvre 2022</a>). </p> <section id="CD007315-sec-0029"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD007315-list-0004"> <li> <p>All‐cause mortality</p> </li> <li> <p>Severe hypoglycaemic episodes</p> </li> <li> <p>Hypoglycaemic episodes</p> </li> <li> <p>Infectious complications</p> </li> </ul> </p> </section> <section id="CD007315-sec-0030"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD007315-list-0005"> <li> <p>Cardiovascular events</p> </li> <li> <p>Renal failure</p> </li> <li> <p>Length of ICU stay</p> </li> <li> <p>Length of hospital stay</p> </li> <li> <p>Health‐related quality of life</p> </li> <li> <p>Socioeconomic effects</p> </li> <li> <p>Weight gain</p> </li> <li> <p>Mean blood glucose during the intervention</p> </li> </ul> </p> <section id="CD007315-sec-0031"> <h6 class="title">Method of outcome measurement</h6> <p> <ul id="CD007315-list-0006"> <li> <p>All‐cause mortality: defined as death from any cause</p> </li> <li> <p>Hypoglycaemic episodes: number of overall, severe and non‐severe hypoglycaemic episodes (subdivided by time of day of occurrence) </p> </li> <li> <p>Infectious complications: any kind of infectious complication (e.g. pneumonia, urinary tract infection) </p> </li> <li> <p>Cardiovascular events: defined as any incidents that may cause damage to the cardiovascular system </p> </li> <li> <p>Renal failure: defined as an elevation of the serum creatinine greater than 2 mg/dL or need for dialysis </p> </li> <li> <p>Length of ICU stay: defined as days admitted to the ICU</p> </li> <li> <p>Length of hospital stay: defined as days admitted to the hospital unit</p> </li> <li> <p>Health‐related quality of life: evaluated by a validated instrument such as QOLS (Quality of Life Scale) or WHOQOL (World Health Organization Quality of Life Questionnaire), SF36 (36‐Item Short Form Survey), etc. </p> </li> <li> <p>Socioeconomic effects: such as direct costs defined as admission or readmission rates; the average length of stay; visits to general practitioner; accident or emergency visits; medication consumption; indirect costs defined as resources lost due to illness by the participant or their family member </p> </li> <li> <p>Weight gain: defined as the difference between the weight (kg) before and after the intervention </p> </li> <li> <p>Mean blood glucose during the intervention: defined as the mean of total glucose values (mg/dL) obtained from the start to the end of the intervention </p> </li> </ul> </p> </section> <section id="CD007315-sec-0032"> <h6 class="title">Timing of outcome measurement</h6> <p> <ul id="CD007315-list-0007"> <li> <p>All‐cause mortality, hypoglycaemic episodes, infectious complications, cardiovascular events, renal failure, health‐related quality of life, socioeconomic effects, weight gain and mean blood glucose: any time after participants were randomised to the intervention/comparator groups </p> </li> <li> <p>Length of ICU and hospital stay: at ICU and hospital discharge</p> </li> </ul> </p> </section> </section> </section> </section> <section id="CD007315-sec-0033"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD007315-sec-0034"> <h4 class="title">Electronic searches</h4> <p>For this update, we searched the following sources from 1 January 2012 to 25 July 2022 and placed no restrictions on the language of publication: </p> <p> <ul id="CD007315-list-0008"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) via the Cochrane Register of Studies Online (CRSO) (last searched on 25 July 2022); </p> </li> <li> <p>MEDLINE OvidSP (Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Ovid MEDLINE Daily and Ovid MEDLINE; from 1946 to present) (last searched on 25 July 2022); </p> </li> <li> <p>LILACS (last searched on 25 July 2022);</p> </li> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>) (last searched on 25 July 2022); </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (ICTRP) (<a href="http://apps.who.int/trialsearch/" target="_blank">www.who.int/trialsearch/</a>) (last searched on 25 July 2022). </p> </li> </ul> </p> <p>We did not include Embase in our search, as RCTs indexed in Embase are now prospectively added to CENTRAL via a highly sensitive screening process (<a href="./references#CD007315-bbs2-0086" title="Cochrane. How CENTRAL is created. www.cochranelibrary.com/central/central-creation (accessed 17 June 2022).">Cochrane 2022</a>). For detailed search strategies, see <a href="./appendices#CD007315-sec-0109">Appendix 1</a>. </p> <p>In addition to the Boolean searches described above, our Information Specialist carried out a PubMed 'Similar articles' search. This search was based on 12 records of included studies from the previous review (see <a href="./appendices#CD007315-sec-0109">Appendix 1</a>). It was conducted on 12 September 2018 and subsequently imported into CRS Web (Cochrane Register of Studies), where the Cochrane RCT classifier was applied and records removed (<a href="./references#CD007315-bbs2-0111" title="MarshallIJ , Noel-StorrAH , KuiperJ , ThomasJ , WallaceBC . Machine learning for identifying randomized controlled trials: an evaluation and practitioner’s guide. Res Synth Methods2018;9(4):602-14. [DOI: 10.1002/jrsm.1287]">Marshall 2018</a>), when they were categorised by the classifier as having less than 74% probability of being an RCT. We screened the records with a probability ≥ 75% together with the search results from the Boolean searches. </p> </section> <section id="CD007315-sec-0035"> <h4 class="title">Searching other resources</h4> <p>We tried to identify other potentially eligible trials or ancillary publications by searching the reference lists of included trials, systematic reviews and meta‐analyses. In addition, we contacted authors of included trials to identify any additional information on the retrieved trials and establish whether we may have missed further trials. </p> <p>We did not use abstracts or conference proceedings for data extraction unless full data were available from trial authors because this information source does not fulfil the CONSORT requirements, which consist of "an evidence‐based, minimum set of recommendations for reporting randomized trials" (<a href="./references#CD007315-bbs2-0087" title="MoherD , SchulzKF , AltmanD , CONSORT Group (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA2001;285(15):1987-1991.">CONSORT 2016</a>; <a href="./references#CD007315-bbs2-0120" title="SchererRW , LangenbergP , vonEE . Full publication of results initially presented in abstracts. Cochrane Database of Systematic Reviews2007, Issue 2. Art. No: MR000005. [DOI: 10.1002/14651858.MR000005.pub3]">Scherer 2007</a>). We presented information on abstracts or conference proceedings in the <a href="./references#CD007315-sec-0140" title="">Characteristics of studies awaiting classification</a> table. </p> </section> </section> <section id="CD007315-sec-0036"> <h3 class="title" id="CD007315-sec-0036">Data collection and analysis</h3> <section id="CD007315-sec-0037"> <h4 class="title">Selection of studies</h4> <p>Two review authors (MH, GG) independently screened the abstract, title, or both, of every record retrieved by the literature searches to determine which trials we should assess further. We obtained the full texts of all potentially relevant records. We resolved any disagreements through consensus or by recourse to a third review author (DM). If we could not resolve a disagreement, we categorised the trial as a 'study awaiting classification' and contacted the trial authors for clarification. We presented an adapted PRISMA flow diagram to show the process of trial selection (<a href="./references#CD007315-bbs2-0116" title="PageMJ , McKenzieJE , BossuytPM , BoutronI , Hoffmann TC MulrowCD , et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews [The PRISMA 2020 statement: an updated guideline for reporting systematic reviews]. BMJ2021;372(71):1-9. [DOI: doi: 10.1136/bmj.n71]">Page 2020</a>). We listed all articles excluded after full‐text assessment in a <a href="./references#CD007315-sec-0139" title="">Characteristics of excluded studies</a> table and provided the reasons for exclusion. </p> </section> <section id="CD007315-sec-0038"> <h4 class="title">Data extraction and management</h4> <p>For studies that fulfilled our inclusion criteria, two review authors (ER, FB) independently extracted key information on participants, interventions and comparators. We described interventions according to the 'template for intervention description and replication' (TIDieR) checklist (<a href="./references#CD007315-bbs2-0100" title="HoffmannTC , GlasziouPP , BoutronI , MilneR , PereraR , MoherD , et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ2014;348:g1687.">Hoffmann 2014</a>; <a href="./references#CD007315-bbs2-0101" title="HoffmannTC , OxmanAD , IoannidisJP , MoherD , LassersonTJ , ToveyDI , et al. Enhancing the usability of systematic reviews by improving the consideration and description of interventions. BMJ2017;358:j2998.">Hoffmann 2017</a>). </p> <p>We reported data on efficacy outcomes and adverse events using standardised data extraction sheets from the CMED Group. We resolved any disagreements by discussion or, if required, by consultation with a third review author (DM) (for details see <a href="./references#CD007315-sec-0138" title="">Characteristics of included studies</a>; <a href="#CD007315-tbl-0002">Table 1</a>; <a href="#CD007315-tbl-0003">Table 2</a>; <a href="./appendices#CD007315-sec-0109">Appendix 1</a>; <a href="./appendices#CD007315-sec-0110">Appendix 2</a>; <a href="./appendices#CD007315-sec-0111">Appendix 3</a>; <a href="./appendices#CD007315-sec-0112">Appendix 4</a>; <a href="./appendices#CD007315-sec-0113">Appendix 5</a>; <a href="./appendices#CD007315-sec-0114">Appendix 6</a>; <a href="./appendices#CD007315-sec-0115">Appendix 7</a>; <a href="./appendices#CD007315-sec-0116">Appendix 8</a>; <a href="./appendices#CD007315-sec-0117">Appendix 9</a>; <a href="./appendices#CD007315-sec-0118">Appendix 10</a>; <a href="./appendices#CD007315-sec-0119">Appendix 11</a>; <a href="./appendices#CD007315-sec-0120">Appendix 12</a>; <a href="./appendices#CD007315-sec-0121">Appendix 13</a>; <a href="./appendices#CD007315-sec-0122">Appendix 14</a>; <a href="./appendices#CD007315-sec-0123">Appendix 15</a>; <a href="./appendices#CD007315-sec-0124">Appendix 16</a>). </p> <div class="table" id="CD007315-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of study population (participants with diabetes undergoing surgery)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study (design)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention(s) and comparator(s)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Description of power and sample size calculation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Screened/eligible (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Randomised (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Analysed (primary outcome) (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Finishing trial (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Randomised finishing trial (%)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Follow‐up</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: hyperinsulinaemic normoglycaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>226*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>226*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>226*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Follow ‐up 30 months</p> <p>475 *</p> <p>Follow‐up 1 year: —</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>249*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>249*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>249*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>475*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>475*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>475*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100*</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive (140)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>1 year follow‐up: 49*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: moderate (180)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>49*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>49*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>49*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100*</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: tight glycaemic control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>30 days follow up: 135</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional moderate glycaemic control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>135</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>135</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>135</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a> </p> <p>Parallel‐group RCT</p> <p>Study terminated early</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: moderately intense control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>With power of 80% and a P value of 0.05 the sample size is 40 recipients per study group </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Follow up 30 days: 58 (97%)</p> <p>Follow up 6 months: 51 (83.3%)</p> <p>Follow up 1 year: 42 (70%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>60</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>60</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>60</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive glycaemic (IG) management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional glycaemic (CG) management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>212</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>212</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>210</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>99</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>152*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conservative group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>152*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>152*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>152*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100*</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a> </p> <p>Parallel‐group RCT</p> <p>Study terminated early</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive glucose management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 103*</p> <p>Follow up 1 year: 103*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional glucose management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign="top"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>103*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>103*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive glycaemic control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"The statistical error rates were established a priori at 0.15 and 0.20 for the type I and type II error rates, respectively. The sample size for the clinical trial was based on feasibility of enrollment along with power to detect a clinically relevant effect size in secondary endpoints (e.g. BG levels and biomarkers) at the P 0.15 level of significance. The upper bound for the recruitment potential of this single clinical site was based on transplant volume. The transplant center estimated approximately 150 renal transplants per year; of these, it was conservatively estimated that approximately 30% of these patients would be have diabetes, eligible, and willing to participate in this study. Thus, approximately 45 patients per year would be the expected accrual annual rate. This rate for a projected accrual period of 27 months would be expected to yield approximately 90 participants in the trial. Using the feasible sample size of 90 participants, there was 80% power to detect an effect size of 0.48 for the secondary outcomes (i.e. a 0.48‐SD difference in continuous outcomes)" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow‐up for at least 2 weeks (interim analysis): 51</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard glycaemic control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>104</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>89</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: strict blood glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>223*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 81*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: liberal blood glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>81*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>81*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>81*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: aggressive glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 82</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: moderate glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="right" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>82</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>82</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>82</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"The minimum required sample size was determined by using an appropriate formula that would provide 80% power to detect a 16% difference in the postoperative complication rate at a 0.05 level (two sided test)" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 28 days: 179</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>179</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>179</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>179</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a> </p> <p>Parallel‐group RCT</p> <p>Study terminated early</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 28 days: 124*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: intermediate glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign="top"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>124*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>124*</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>213*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>213*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>203*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 90 days: 402*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>208*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>208*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>199*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>421*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>421*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>402*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>95</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a> </p> <p>Parallel‐group RCT</p> <p>Study terminated early</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: continuous insulin infusion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 126</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard intermittent insulin bolus</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign="top"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>126</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>126</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a><sup>a</sup> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive Insulin treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 32*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional insulin treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>32*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>32*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>32*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 28 days: 13*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>13*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>13*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>13*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100*</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 73</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>78</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>73</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>73</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>94</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a><sup>b</sup> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: continuous insulin infusion (CII)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: glucometer‐guided insulin (GGI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: tight glycaemic control with GIK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 141</p> <p>Follow up 5 years: 120</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>141</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>141</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>141</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: aggressive insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"Using published data, we determined that group sizes of 13 patients per study group would give us 84% power to detect a significant (20%) increase in Polymorphonuclear neutrophils function in the treatment groups after surgery at a 5% level of significance" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>26</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>26</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>26</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Grand total</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>All interventions</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1320</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1316</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>All comparators</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1350</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1333</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>All interventions and comparators</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>2670</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>2649</b> </p> </th> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>From the total population 11 participants withdrew from both groups after randomisation.<br/><sup>b</sup>Seven participants in the control group dropped out of the study after surgery and were switched to the intervention regimen because their personal surgeon considered their degree of blood glucose control to be unacceptable. </p> <p>Number of randomised participants in <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a> and <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a> not available; ITT population used instead. </p> <p>*Data provided by study authors.</p> <p>—: not reported</p> <p><b>C</b> : control group; <b>GIK</b> : glucose‐insulin‐potassium; <b>I</b> : intervention group; <b>ITT</b> : intention‐to‐treat: <b>RCT</b>: randomised controlled trial. </p> </div> </div> <div class="table" id="CD007315-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overview of study population (total participants of studies)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study (design)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention(s) and comparator(s)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Description of power and sample size calculation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Screened/eligible (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Randomised (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Analysed (primary outcome) (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Finishing trial (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Randomised finishing trial (%)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Follow‐up</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: hyperinsulinaemic normoglycaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"A maximum of 2,790 patients was required to detect a 30% relative reduction in the composite of any major complications (i.e., any vs. none) from an expected 15% incidence of complications in the standard group at the overall 0.05 significance level with 90% power" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days:</p> <p>1439</p> <p>Follow up 1 year: 1335</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>730</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>730</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>730</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1439</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1439</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1439</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive (140 group)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"Based on our cross‐sectional analyses, the 1‐year rejection rate in the 140‐mg/dL group was assumed to be 20% and in the 180‐mg/dL group was assumed to be 44%. Using these rates, we estimated that a total sample size of 136 patients, 68 in each group, would give us 80% power (a = 0.05, 2‐sided) to detect a statistically significant difference between these groups. We estimated a potential withdrawal rate of 20%, giving a total of 82 patients in each group, for a total of 164 patients to be randomized" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>733</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>1 year follow‐up: 164</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: moderate (180 group)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>164</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>164</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>164</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: tight glycaemic control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 days follow‐up: 67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional moderate glycaemic control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 days follow‐up: 68</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>135</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>135</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>135</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a> </p> <p>Parallel‐group RCT</p> <p>Study terminated early</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: moderately intense control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"With a power of 80% and P‐value of.05, we estimated a needed sample size of 40 recipients per study group" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>327 (69)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Follow up 30 days: 58</p> <p>Follow up 6 months: 51</p> <p>Follow up 1 year: 42</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>60</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>60</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>60</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive glycaemic (IG) management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional glycaemic (CG) management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>212</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>212</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>210</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>99</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"Sample size was based on previous studies by van den Berghe et al. and Umpierrez et al. We estimated an incidence rate of the primary end point in the control group of 20% and odds ratio for the intensive versus conservative glucose control group of 0.35. We expected a low attrition rate of, 10% in the ICU; using two sided Fisher exact test, with a = 0.05, we estimated that the sample size required for 80% power to be 148 patients per group (a total of 296 patients) for the primary end point. For all analyses, reported P values are two‐sided, and P values 0.05 were considered significant. All analyses were performed using SAS software version 9.2 (SAS Institute, Cary, NC)" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>855</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Follow‐up 90 days after discharge</p> <p>151</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conservative group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>305</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>302</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>302</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>99</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a> </p> <p>Parallel‐group RCT</p> <p>Study terminated early</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive glucose management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"A maximum of 970 total patients were required to have 90% power at the 0.05 significance level to detect a 40% relative reduction on the primary outcome for the most effective intervention (whichever of the three), assuming effects of 20% and 10% for the other two interventions. If only one of the three factors had any effect, we had 90% power to detect a slightly narrower 37% relative reduction" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Follow up 30 days: 381</p> <p>Follow up 1 year: 381</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional glucose management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>381</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>381</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>381</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive glycaemic control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"The statistical error rates were established a priori at 0.15 and 0.20 for the type I and type II error rates, respectively. The sample size for the clinical trial was based on feasibility of enrollment along with power to detect a clinically relevant effect size in secondary endpoints (e.g. BG levels and biomarkers) at the P 0.15 level of significance. The upper bound for the recruitment potential of this single clinical site was based on transplant volume. The transplant center estimated approximately 150 renal transplants per year; of these, it was conservatively estimated that approximately 30% of these patients would have diabetes, eligible, and willing to participate in this study. Thus, approximately 45 patients per year would be the expected accrual annual rate. This rate for a projected accrual period of 27 months would be expected to yield approximately 90 participants in the trial. Using the feasible sample size of 90 participants, there was 80% power to detect an effect size of 0.48 for the secondary outcomes (i.e. a 0.48‐SD difference in continuous outcomes)" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Follow‐up for at least 2 weeks (interim analysis): 51</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard glycaemic control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>104</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>89</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: strict blood glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"The a priori sample size of this study (N=200) was determined to be sufficient using a medium effect size, an alpha level of 0.05, and 80% power.20 Observed power was found to be robust for significant results, but not robust for nonsignificant results as expected, given the much smaller observed effect sizes for those comparisons" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>223</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 189</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: liberal blood glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>189</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>189</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>189</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: aggressive glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 82</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: moderate glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="right" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>82</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>82</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>82</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>82</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"The minimum required sample size was determined by using an appropriate formula that would provide 80% power to detect a 16% difference in the postoperative complication rate at a 0.05 level (two‐sided test)" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 28 days: 179</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>179</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>179</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>179</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a> </p> <p>Parallel‐group RCT</p> <p>Study terminated early</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"The power of the sample size of 1,078 patients to detect a 4% difference in ICU mortality with an alpha error rate of 5% and beta error rate of 20% was 32%. </p> <p>The expected mortality in the ‘‘control’’ group (group 1) was based on the data recorded in the preliminary survey and was used to calculate the sample size needed to detect a 4% decrease in mortality with an alpha error rate of 5% and beta error rate of 20% (n = 1,496 patients in each group). A total of 1,750 patients per group were deemed necessary to account for drop‐outs" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>7747</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>536</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>536</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 28 days: 1078</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: intermediate glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>551</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>542</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>542</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1101</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1078</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1078</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>98</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"The study was originally designed to enroll 4000 patients. On the basis of data reported by Van den Berghe et al. in 2006, 13 the sample size was increased to 6100, thereby providing a statistical power of 90% to detect an absolute difference in mortality between the two groups of 3.8 percentage points, assuming a baseline mortality of 30% at a two‐sided alpha level of less than 0.05" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>40,171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3054</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3054</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>90 days follow‐up</p> <p>6022</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3050</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3050</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>6104</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>6104</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>6022</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>99</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a> </p> <p>Parallel‐group RCT</p> <p>Study terminated early</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: continuous insulin infusion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"A conservative estimate of 5% rate of MACEs in patients undergoing vascular surgery was assumed for the current study. Assuming a 10% dropout rate, this study needed 993 patients in each group to show a 50% reduction in MACEs for 80% (1‐Beta) power and a statistical significance of P 0.05 (alfa) in patients receiving continuous intravenous insulin infusion compared with conventional therapy. An interim analysis was planned at 452 patients" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 236</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard intermittent insulin bolus</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>242</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>236</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>236</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>98</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive Insulin treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow‐up 30 days: 98</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional insulin treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>109</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>109</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>98</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>90</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"We estimated that the enrollment of 504 patients would provide a power of 80% to detect an absolute reduction of 10% in the 28‐day mortality rate with an alpha error (two‐sided test) of 0.05. We assumed a 25% mortality rate in the control group" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1643</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 28 days: 502</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>504</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>504</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>502</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>99</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"On the basis of a composite outcome rate of 40% in the conventional treatment group. We needed to enroll 177 patients per treatment group to have 90% power (2‐sided " level of 0.05) of finding a 40% decrease in the composite outcome with intensive insulin therapy (decrease from 40% to 24%). Because we expected that approximately 10% of patients would not experience hyperglycemia during surgery, we randomly assigned 200 patients per treatment group to ensure a sufficient number with outcome information" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>502</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 371</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>400</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>379</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>371</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: continuous insulin infusion (CII)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: glucometer‐guided insulin (GGI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: tight glycaemic control with GIK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 141</p> <p>Follow up 5 years: 120</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>141</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>141</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>141</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"Using published data, we determined that group sizes of 13 patients per study group would give us 84% power to detect a significant (20%) increase in Polymorphonuclear neutrophils function in the treatment groups after surgery at a 5% level of significance" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>26</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>26</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>26</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Grand total</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>All interventions</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>5981</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>5887</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>All comparators</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>5996</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>5914</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>All interventions and comparators</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>11,977</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>11,801</b> </p> </th> </tr> </tbody> </table> <div class="table-footnote"> <p>Number of randomised participants in <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a> and <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a> not available; ITT population used instead. </p> <p>*Data provided by study authors.</p> <p>—: not reported</p> <p><b>C</b> : control group; <b>GIK</b> : glucose‐insulin‐potassium; <b>I</b> : intervention group; <b>ITT</b> : intention‐to‐treat; <b>RCT</b>: randomised controlled trial. </p> </div> </div> <p>We provided information, including the study identifier for potentially relevant ongoing trials in the <a href="./references#CD007315-sec-0141" title="">Characteristics of ongoing studies</a> table and in <a href="./appendices#CD007315-sec-0117">Appendix 9</a> 'Matrix of trial endpoint (publications and trial documents)'. We attempted to find the protocol for each included study, and we reported in <a href="./appendices#CD007315-sec-0117">Appendix 9</a> the primary, secondary and other outcomes from these protocols, alongside the date from the study publications. </p> <p>We emailed all authors of included trials to enquire whether they would be willing to answer questions regarding their trials. We presented the results of this survey in <a href="./appendices#CD007315-sec-0125">Appendix 17</a>. We thereafter sought relevant missing information on the trial from the primary trial author(s), if required. </p> </section> <section id="CD007315-sec-0039"> <h4 class="title">Dealing with duplicate and companion publications</h4> <p>In the event of duplicate publications, companion documents or multiple reports of a primary trial, we maximised the information yield by collating all available data, and we used the most complete data set aggregated across all known publications. We listed duplicate publications, companion documents, multiple reports of a primary trial and trial documents of included trials (such as trial registry information) as secondary references under the study ID of the included trial. Furthermore, we also listed duplicate publications, companion documents, multiple reports of a trial and trial documents of excluded trials (such as trial registry information) as secondary references under the study ID of the excluded trial. </p> </section> <section id="CD007315-sec-0040"> <h4 class="title">Data from clinical trials registers</h4> <p>If data from included studies were available as study results in clinical trials registers, such as <a href="http://ClinicalTrials.gov" target="_blank">ClinicalTrials.gov</a> or similar sources, we made full use of this information and extracted the data. If there was also a full publication of the study, we collated and critically appraised all available data. If an included study was marked as a completed study in a clinical trial register but no additional information was available (study results, publication, or both), we added this study to the <a href="./references#CD007315-sec-0140" title="">Characteristics of studies awaiting classification</a> table. </p> </section> <section id="CD007315-sec-0041"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (IS, FB) independently assessed the risk of bias for each included trial. We resolved disagreements by consensus or by consulting a third review author (DM). In the case of disagreement, we consulted the remainder of the review author team and made a judgement based on consensus. If adequate information was unavailable from the trial publications, trial protocols or other sources, we contacted the trial authors for more detail to request missing data on risk of bias items. </p> <p>We used the Cochrane risk of bias assessment tool (<a href="./references#CD007315-bbs2-0099" title="HigginsJP , SavovićJ , PageMJ , ElbersRG , SterneJA . Chapter 8: Assessing risk of bias in a randomized trial. . In: Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019.">Higgins 2019b</a>), assigning assessments of low, high or unclear risk of bias (for details see <a href="./appendices#CD007315-sec-0110">Appendix 2</a>; <a href="./appendices#CD007315-sec-0111">Appendix 3</a>). We evaluated individual bias items as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> according to the criteria and associated categorisations contained therein (<a href="./references#CD007315-bbs2-0099" title="HigginsJP , SavovićJ , PageMJ , ElbersRG , SterneJA . Chapter 8: Assessing risk of bias in a randomized trial. . In: Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019.">Higgins 2019b</a>). </p> <section id="CD007315-sec-0042"> <h5 class="title">Summary assessment of risk of bias</h5> <p>We presented a risk of bias graph and a risk of bias summary figure.</p> <p>We distinguished between self‐reported and investigator‐assessed and adjudicated outcome measures. </p> <p>We considered the following self‐reported outcomes.</p> <p> <ul id="CD007315-list-0009"> <li> <p>Health‐related quality of life</p> </li> </ul> </p> <p>We considered the following outcomes to be investigator‐assessed.</p> <p> <ul id="CD007315-list-0010"> <li> <p>All‐cause mortality</p> </li> <li> <p>Hypoglycaemic episodes</p> </li> <li> <p>Cardiovascular events</p> </li> <li> <p>Renal failure</p> </li> <li> <p>Length of ICU stay</p> </li> <li> <p>Length of hospital stay</p> </li> <li> <p>Socioeconomic effects</p> </li> <li> <p>Weight gain</p> </li> <li> <p>Mean blood glucose during the intervention</p> </li> </ul> </p> <section id="CD007315-sec-0043"> <h6 class="title">Risk of bias for a trial across outcomes</h6> <p>Some risk of bias domains, such as selection bias (random sequence generation and allocation sequence concealment), affect the risk of bias across all outcome measures in a trial. In case of a high risk of selection bias, we marked all endpoints investigated in the associated trial as being at high risk. Otherwise, we did not perform a summary assessment of the risk of bias across all outcomes for a study. </p> </section> <section id="CD007315-sec-0044"> <h6 class="title">Risk of bias for an outcome within a trial and across domains</h6> <p>We assessed the risk of bias for an outcome measure by including all entries relevant to that outcome (i.e. both trial‐level entries and outcome‐specific entries). We considered a low risk of bias to denote a low risk of bias for all key domains, an unclear risk to denote an unclear risk of bias for one or more key domains and a high risk to denote a high risk of bias for one or more key domains. </p> </section> <section id="CD007315-sec-0045"> <h6 class="title">Risk of bias for an outcome across trials and across domains</h6> <p>To facilitate our assessment of the certainty of the evidence for key outcomes, we assessed the risk of bias across studies and domains for the outcomes included in the summary of findings table. We defined the evidence as being at low risk of bias when most information came from trials at low risk of bias, unclear risk of bias when most information came from studies at a low or unclear risk of bias, and high risk of bias when a sufficient proportion of information came from studies at high risk of bias. </p> </section> </section> </section> <section id="CD007315-sec-0046"> <h4 class="title">Measures of treatment effect</h4> <p>When at least two included trials were available for a comparison and a given outcome, we tried to express dichotomous data as a risk ratio (RR) with 95% confidence interval (CI). For continuous outcomes measured on the same scale (e.g. weight gain in kg) we estimated the intervention effect using the mean difference (MD) with 95% CI. For continuous outcomes that measured the same underlying concept (e.g. health‐related quality of life), but used different measurement scales, we calculated the standardised mean difference (SMD). If data had been available, we would have expressed time‐to‐event outcomes as a hazard ratio (HR) with 95% CI. </p> </section> <section id="CD007315-sec-0047"> <h4 class="title">Unit of analysis issues</h4> <p>We took into account the level at which randomisation occurred, such as cross‐over trials, cluster‐randomised trials and multiple observations for the same outcome. If more than one comparison from the same trial was eligible for inclusion in the same meta‐analysis, we either combined groups to create a single pair‐wise comparison or appropriately reduced the sample size so that the same participants did not contribute data to the meta‐analysis more than once (splitting the 'shared' group into two or more groups). While the latter approach offers some solutions for adjusting the precision of the comparison, it does not account for correlation arising from the same set of participants being in multiple comparisons (<a href="./references#CD007315-bbs2-0098" title="HigginsJP , LiT , Deeks JJ (editors). Chapter 6: Choosing effect measures and computing estimates of effect.. In: Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019.">Higgins 2019a</a>). </p> <p>If we had included cluster‐RCTs, we would have attempted some re‐analyses. We would have attempted to re‐analyse cluster‐RCTs that had not appropriately adjusted for the potential clustering of participants within clusters in their analyses. In these cases, the variance of the intervention effects was inflated by a design effect. Calculation of a design effect involves the estimation of an intracluster correlation coefficient (ICC). We would have obtained estimates of ICCs by contacting trial authors or imputing the ICC values by using either an estimate from other included trials that report ICCs or external estimates from empirical research (e.g. <a href="./references#CD007315-bbs2-0080" title="BellML , McKenzieJE . Designing psycho-oncology randomised trials and cluster randomised trials: variance components and intra-cluster correlation of commonly used psychosocial measures. Psycho-oncology2013;22:1738-47.">Bell 2013</a>). In these cases, we also planned to examine the impact of clustering using sensitivity analyses. </p> </section> <section id="CD007315-sec-0048"> <h4 class="title">Dealing with missing data</h4> <p>If possible, we obtained missing data from the authors of the included trials. We carefully evaluated important numerical data such as screened, randomly assigned participants as well as intention‐to‐treat, as‐treated and per‐protocol populations. We investigated attrition rates (e.g. dropouts, losses to follow‐up and withdrawals), and we critically appraised issues concerning missing data and the use of imputation methods (e.g. last observation carried forward). </p> <p>In trials where the standard deviation (SD) of the outcome was not available at follow‐up, or we could not recreate it, we standardised by the mean of the pooled baseline SD from those trials that reported this information. </p> <p>Where included trials did not report means and SDs for outcomes, and we did not receive the necessary information from trial authors, we imputed these values by estimating the mean and variance from the median, range and size of the sample (<a href="./references#CD007315-bbs2-0102" title="HozoSP , DjulbegovicB , HozoI . Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology2005;5:13. [DOI: 10.1186/1471-2288-5-13]">Hozo 2005</a>). </p> <p>We investigated the impact of imputation on meta‐analyses by performing sensitivity analyses, and we reported for every outcome that trials had imputed SDs. </p> </section> <section id="CD007315-sec-0049"> <h4 class="title">Assessment of heterogeneity</h4> <p>In the event of substantial clinical, methodological or statistical heterogeneity, we did not report trial results as the pooled effect estimate in a meta‐analysis. We identified heterogeneity (inconsistency) by visually inspecting the forest plots and by using a standard Chi<sup>2</sup> test with a significance level of α = 0.1 (<a href="./references#CD007315-bbs2-0089" title="DeeksJJ , HigginsJP , Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. In: DeeksJJ , HigginsJPT , AltmanDG , editors(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021.">Deeks 2019</a>). In view of the low power of this test, we also considered the I<sup>2</sup> statistic, which quantifies inconsistency across studies, to assess the impact of heterogeneity on the meta‐analysis (<a href="./references#CD007315-bbs2-0096" title="HigginsJP , ThompsonSG . Quantifying heterogeneity in a meta-analysis. Statistics in Medicine2002;21:1539-58.">Higgins 2002</a>; <a href="./references#CD007315-bbs2-0097" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60.">Higgins 2003</a>). When we identified heterogeneity, we attempted to determine potential reasons for this by examining individual characteristics of the study and subgroups. </p> </section> <section id="CD007315-sec-0050"> <h4 class="title">Assessment of reporting biases</h4> <p>If we included 10 or more studies that investigated a particular outcome, we used funnel plots to assess small study effects. Several explanations may account for funnel plot asymmetry, including true heterogeneity of effect with respect to study size, poor methodological design (and hence bias of small studies) and selective non‐reporting (<a href="./references#CD007315-bbs2-0109" title="KirkhamJJ , DwanKM , AltmanDG , GambleC , DoddS , SmythR , et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ2010;340:c365. [DOI: 10.1136/bmj.c365]">Kirkham 2010</a>). Therefore, we interpreted the results carefully (<a href="./references#CD007315-bbs2-0124" title="SterneJA , SuttonAJ , IoannidisJP , TerrinN , JonesDR , LauJ , et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ2011;343:d4002.">Sterne 2011</a>). </p> </section> <section id="CD007315-sec-0051"> <h4 class="title">Data synthesis</h4> <p>We planned to undertake (or display) a meta‐analysis only if we judged the participants, interventions, comparisons and outcomes to be sufficiently similar to ensure a result that was clinically meaningful. Unless good evidence showed homogeneous effects across trials of different methodological quality, we primarily summarised data with a low risk of bias using a random‐effects model (<a href="./references#CD007315-bbs2-0130" title="WoodL , EggerM , GluudLL , SchulzKF , JüniP , AltmanDG , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ2008;336(7644):601-5.">Wood 2008</a>). We interpreted random‐effects meta‐analyses with due consideration to the whole distribution of effects and presented a confidence interval. We performed statistical analyses according to the statistical guidelines presented in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007315-bbs2-0089" title="DeeksJJ , HigginsJP , Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. In: DeeksJJ , HigginsJPT , AltmanDG , editors(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021.">Deeks 2019</a>). </p> </section> <section id="CD007315-sec-0052"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We did not expect that specific characteristics from the included studies could introduce clinical heterogeneity and did not carry out subgroup analyses to explore interactions (<a href="./references#CD007315-bbs2-0078" title="AltmanDG , BlandJM . Interaction revisited: the difference between two estimates. BMJ2003;326(7382):219. [PMID: 12543843]">Altman 2003</a>). </p> </section> <section id="CD007315-sec-0053"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to restrict the analyses (when applicable) to the following factors to explore their impact on effect sizes: </p> <p> <ul id="CD007315-list-0011"> <li> <p>Published data: excluding unpublished data.</p> </li> <li> <p>Risk of bias: excluding studies at an overall high or unclear risk of bias.</p> </li> <li> <p>Long‐lasting or large studies to establish how much they dominate the results: excluding smaller studies. </p> </li> </ul> </p> </section> <section id="CD007315-sec-0054"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <section id="CD007315-sec-0055"> <h5 class="title">Certainty of the evidence</h5> <p>We presented the overall certainty of the evidence for each outcome specified below, according to the GRADE approach, which takes into account issues related not only to internal validity (risk of bias, inconsistency, imprecision, publication bias) and external validity (such as directness of results)<i>.</i> Two review authors (IS, FB) independently rated the certainty of the evidence for each outcome. We resolved any differences in assessment by discussion or consulting a third review author (DM). </p> <p>We included an appendix entitled 'Checklist to aid consistency and reproducibility of GRADE assessments' to help with the standardisation of the summary of findings tables (<a href="./references#CD007315-bbs2-0113" title="MeaderN , KingK , LlewellynA , NormanG , BrownJ , RodgersM , et al. A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Systematic Reviews2014;3:82.">Meader 2014</a>). Alternatively, we used the GRADEpro Guideline Development Tool (GDT) software and presented evidence profile tables as an appendix (<a href="./references#CD007315-bbs2-0094" title="GRADEpro GDT: GRADEpro Guideline Development Tool. Hamilton (ON): McMaster University and Evidence Prime,, 2015. gradepro.org..">GRADEproGDT 2015</a>). We presented results for the outcomes as described in the <a href="#CD007315-sec-0028">Types of outcome measures</a> section. If meta‐analysis was not possible, we presented the results in a narrative format in the summary of findings table. We justified all decisions to downgrade the quality of trials using footnotes and made comments to aid the reader's understanding of the Cochrane Review where necessary. </p> </section> <section id="CD007315-sec-0056"> <h5 class="title">Summary of findings table</h5> <p>We presented a summary of the evidence in a summary of findings table. This provided key information about the best estimate of the magnitude of the effect, in relative terms and as absolute differences, for each relevant comparison of alternative management strategies, the numbers of participants and studies addressing each important outcome and a rating of overall confidence in effect estimates for each outcome. We created the summary of findings table based on the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007315-bbs2-0121" title="SchünemannHJ , HigginsJP , VistGE , GlasziouP , AklEA , SkoetzN , et al. Chapter 14: Completing ‘Summary of findings’ tables and grading the confidence in or quality of the evidence. . In: Cochrane Handbook for Systematic Reviews of Interventions version 6.0 . Cochrane, 2019.">Schünemann 2019</a>) and Review Manager 5 software (<a href="./references#CD007315-bbs2-0118" title="Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2020.">Review Manager 2020</a>). </p> <p>The intervention presented in the summary of findings table was intensive glucose control. The comparator was conventional glucose control. </p> <p>We reported the following outcomes, listed according to priority.</p> <p> <ul id="CD007315-list-0012"> <li> <p>All‐cause mortality</p> </li> <li> <p>Severe hypoglycaemic episodes</p> </li> <li> <p>Infectious complications</p> </li> <li> <p>Cardiovascular events</p> </li> <li> <p>Renal failure</p> </li> <li> <p>Length of ICU stay</p> </li> <li> <p>Length of hospital stay</p> </li> </ul> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007315-sec-0057" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007315-sec-0057"></div> <section id="CD007315-sec-0058"> <h3 class="title">Description of studies</h3> <p>For a detailed description of trials, see <a href="#CD007315-tbl-0002">Table 1</a> and the <a href="./references#CD007315-sec-0138" title="">Characteristics of included studies</a>, <a href="./references#CD007315-sec-0139" title="">Characteristics of excluded studies</a>, <a href="./references#CD007315-sec-0140" title="">Characteristics of studies awaiting classification</a> and <a href="./references#CD007315-sec-0141" title="">Characteristics of ongoing studies</a> sections. </p> <section id="CD007315-sec-0059"> <h4 class="title">Results of the search</h4> <p>The database search yielded a total of 4231 records. After the removal of duplicates, we had 3706 records for title and abstract screening. We excluded 3648 by title and abstract. We screened a total of 58 records for eligibility. After obtaining full‐text articles, we excluded 40 studies for the following reasons: irrelevance to our research topic, not an RCT, not on participants with diabetes and undergoing surgery, not a more intensive versus conventional intervention, suspended study or outcome data for people with diabetes were not available separately. No unpublished studies were identified. We identified two registered ongoing trials (<a href="./references#CD007315-bbs2-0069" title="NCT02032953. Enhancing the anabolic effect of perioperative nutrition with insulin while maintaining normoglycemia. https://clinicaltrials.gov/ct2/show/NCT02032953 (first received 10 January 2014). ">NCT02032953</a>; <a href="./references#CD007315-bbs2-0070" title="NCT04742023. Post-operative complications and graft survival with conventional versus continuous glucose monitoring in patients with diabetes mellitus undergoing renal transplantation. https://clinicaltrials.gov/ct2/show/NCT04742023 (first received 5 February 2021). ">NCT04742023</a>), and listed eight records as trials awaiting classification. </p> <p>Finally, incorporating eight additional studies with the 12 studies from the previous review, in this update 20 trials met our inclusion criteria (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). </p> <p>All included studies were published in English. For a detailed description of the search results and selection procedure, see <a href="#CD007315-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD007315-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="original image" data-id="CD007315-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> <section id="CD007315-sec-0060"> <h4 class="title">Included studies</h4> <p>A detailed description of the included trials is presented elsewhere (see <a href="./references#CD007315-sec-0138" title="">Characteristics of included studies</a>). The following is a succinct overview. </p> <section id="CD007315-sec-0061"> <h5 class="title">Source of data</h5> <p>The results of nine trials were published as original papers in scientific journals between 1999 and 2016, and additional data were obtained from entries at <a href="https://clinicaltrials.gov/" target="_blank">https://clinicaltrials.gov/</a>. We contacted 26 trial authors to request separate data from people with diabetes; 12 of the authors replied, and 11 of them provided relevant information and the requested data. For the exact data, see <a href="./appendices#CD007315-sec-0125">Appendix 17</a>. </p> </section> <section id="CD007315-sec-0062"> <h5 class="title">Comparisons</h5> <p>All included trials compared an intensive glycaemic control with lower perioperative blood glucose values to less intensive glycaemic control with higher perioperative blood glucose values. </p> <p>There were considerable differences between studies regarding perioperative intensive glycaemic control. The vast majority of the trials used a continuous infusion of insulin in a saline solution (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). One study used an algorithm for an intravenous bolus of insulin in addition to a continuous infusion of insulin (<a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>), and in one study the choice of bolus therapy or insulin infusion was left to the discretion of the anaesthesia team members (<a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>). In three studies, the study protocol controlled the insulin infusion, but the saline infusion and others were controlled by an anaesthesiologist (<a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>). In two of the trials, it was the treatment protocol that determined insulin and glucose infusion (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>). Finally, two studies used a glucose‐insulin‐potassium infusion to control the blood glucose of participants (<a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>). </p> <p>Blood glucose target levels varied between the studies from a very strict control (blood glucose target equal or less than 120 mg/dL) (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>), to less strict control (blood glucose target equal to or less than 200 mg/dL) (<a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>). Four studies used an intermediate glucose control (blood glucose target equal to or less than 160 mg/dL) (<a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>). One study targeted blood glucose between strict and intermediate control (blood glucose target between 80 mg/dL and 160 mg/dL) (<a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>), and in one study no blood glucose target was defined: insulin infusion was started only whenever blood glucose levels exceeded 150 mg/dL (<a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>). </p> <p>In the majority of the trials, blood glucose was measured hourly until blood glucose was stable, following two‐hour measurements. In six studies blood glucose was measured more often, every half hour (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>), every 15 to 30 minutes (<a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>), and every 10 to 15 minutes (<a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>). In one study variable times of measurement were used following the algorithms of the glucommander (<a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>), and one study did not mention how often blood glucose measurements were done (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>). </p> <p>We can observe variations in the time points during the perioperative period when participants were undergoing the intervention. In nine trials the intervention happened in the intensive care unit (ICU), i.e. in the postoperative period when the treatment was started within 24 hours after the surgery (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). Another nine studies began after induction of anaesthesia and the intervention was continued postoperatively (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>). Intensive glycaemic control was performed only during the surgery in two other studies (<a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>). </p> <p>We also noticed variations between studies in the control group intervention. In 11 studies the difference from the intervention group was a higher blood glucose target only (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>). In one trial, the blood glucose target in the control group was less intensive and during surgery an anaesthetist treated blood glucose at their discretion using intravenous insulin (<a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>). In one study, an intravenous insulin bolus was used to control blood glucose instead of continuous insulin infusion; postoperatively, after the intervention was finished, the blood glucose was controlled in the same way as in the intervention group (<a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>). In three studies, blood glucose in the control group was controlled using subcutaneous insulin bolus (<a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). Two trials used the same glucose target as in the intervention group (<a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>); the two groups differed in blood glucose measurements. Participants in the control group received less frequent blood glucose measurements (every two hours instead of every hour in <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a> and every four hours instead of every hour in <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>). This difference in measurement determines the administration of insulin and better control of the blood glucose, therefore we considered the intervention more intensive than the control group. In the control groups of these studies, a subcutaneous insulin bolus method was used. One trial did not define blood glucose targets, but the control group received a regular insulin bolus if blood glucose transcended 200 mg/dL, compared with a blood glucose of more than 150 mg/dL in the intervention group (<a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>). </p> </section> <section id="CD007315-sec-0063"> <h5 class="title">Overview of trial populations</h5> <p>The 20 included studies had a total of 2670 participants with diabetes undergoing surgery that were randomised to the different comparison groups. The total sample sizes ranged from 26 to 6104 participants per study, and when restricted to participants with diabetes only from 13 to 475 participants per study. Randomised participants finishing the trial were between 93% and 100%. </p> </section> <section id="CD007315-sec-0064"> <h5 class="title">Trial design</h5> <p>All 20 included studies had a parallel and superiority design. All trials made use of a control group where a less intensive blood glucose target was determined or a less intensive way of treatment was implemented. There were four trials with a multicentre design with the number of centres ranging from two to 42 (<a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>). </p> <p>All trials were reported as open‐label. Neither participants nor personnel were blinded. The outcome assessors were reported to be blinded in various trials (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>). In the rest of the included trials blinding of outcome assessors was not reported. </p> <p>Included trials were performed between 1996 and 2016. Intervention duration ranged from the duration of surgery to five days postoperative. The majority of the studies did not report the exact duration of the intervention, only that the intervention was stopped after discharge at the ICU. One study did not report any details on the duration of the intervention (<a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). Follow‐up duration ranged between discharge from ICU stay and five years. Three studies did not report their follow‐up period (<a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). None of the trials had run‐in periods. </p> <p>Three trials were terminated early, one because of a high rate of unintended protocol violations (<a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>), and one because of slow recruitment, the implementation of a more aggressive blood glucose control protocol in the hospital and an increase in minimally invasive surgery techniques (<a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>). One trial was stopped after the second interim analysis at which all three interventions crossed the futility boundary for the primary outcome (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>) </p> </section> <section id="CD007315-sec-0065"> <h5 class="title">Settings</h5> <p>Most of the trials were performed in the United States (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>), one in Canada, one in Egypt, one in Brazil, one in Lebanon and one in Colombia, respectively (<a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>). Three studies were performed in China (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). One study was performed in study centres in Austria, Belgium, France, Israel, The Netherlands, Slovenia and Spain (<a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>), and one in study centres in Austria, New Zealand, Canada and America (<a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>). </p> </section> <section id="CD007315-sec-0066"> <h5 class="title">Participants</h5> <p>The mean age of the participants included was 63 years, ranging from 56 to 73 years (where age was not available for the surgical population with diabetes, that of the total study population was used). Females represented less than 50% in most trials; only in two of them were men less than 50% (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>, <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>), and in another study female representation was around 50% (<a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>). </p> <p>Slightly less than half of the studies exclusively included participants with diabetes (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>); the other studies included both participants with and without diabetes (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>). In five studies, the surgery was a coronary artery bypass graft (<a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>), and in two a possible combination with other cardiac procedures (<a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>). In three studies, the participants were undergoing cardiac surgery (<a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>); one of these also included major lower extremity amputation (<a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>). In five trials, cardiopulmonary bypass surgery was performed (<a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>). In two studies, participants underwent gastrectomy for gastric tumours (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). In three studies, the inclusion criteria were to be admitted to the ICU (<a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>); in this regard, <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a> required a minimum stay of two days. Three studies included participants undergoing renal transplantation (<a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>) and liver transplantation (<a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>). One study enrolled participants having elective major non‐cardiac surgery with two or more hours of general anaesthesia (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>). </p> <p>Five trials were from low‐and middle‐income countries (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>), representing 26% of the total included participants. </p> <p>Ethnicity was reported in seven studies. In five studies more than 70% of participants were white/Caucasian (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>). <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a> differentiated Caucasians from Icelanders, representing 17% and 45%, respectively. Also, <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a> distinguished between White and African‐Americans (37% and 64%, respectively). </p> <p>Only six of the 20 included studies reported the duration of diabetes of the participants. In these studies, the duration of the disease was balanced between the control and intervention groups. In the control group versus the intervention group, the mean duration of diabetes (in years) was 10.5 versus 10.6 (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>), 5.5 versus 6 (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>), 18.6 versus 21.1 (<a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>), 10.9 versus 10.8 (<a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>), and 6.2 versus 5.8 (<a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>), respectively. </p> <p>The mean body mass index (BMI) (kg/m<sup>2</sup>) was well‐balanced between the intervention and control groups. In the intervention group, the mean BMI ranged from 21.1 to 33.5 and in the control groups from 21.6 to 32.1. BMI was not recorded in five studies (<a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>). </p> <p>The mean HbA1c at baseline was reported in nine studies (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>), with a mean value ranging from 6.5% to 8.4% in the intervention group and from 6.7% to 8.3% in the control group. In <a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a> these data are extracted from the total trial population. </p> <p>Fifteen out of 20 studies reported co‐morbidities. Cardiovascular disease is reported in all studies, including hypertension, heart failure, myocardial infarction and atrial fibrillation. In this regard, <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a> only considers arterial hypertension. Cerebrovascular disease is reported in most of the studies (<a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>), and peripheral vascular disease in two (<a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>). With regard to respiratory disease, it was reported in six studies (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). Data on renal disease were also collected in <a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>, <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>, <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>, <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>, <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>, <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>, <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>, <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a> and <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>, and liver disease in <a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>, <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>, <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a> and <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>. Other co‐morbidities covered included cancer (<a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>), coronary artery bypass grafting (<a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>), coagulopathy (<a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>), and dyslipidaemia (<a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>). <a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a> encompasses any type of co‐morbidity. </p> <p>Thirteen of the 20 studies reported concomitant medication. Ten described the treatment for diabetes (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). Other medical regimes are described, such as angiotensin‐converting‐enzyme (ACE) inhibitors and beta‐blockers (<a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>), steroids (<a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>), aspirin (<a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>) or cox‐2 inhibitors (<a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>), lipid‐lowering medication (<a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>), diuretics (<a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>), vasopressors/inotropes (<a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>), and antiarrhythmic medication (<a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>). </p> <p>Several exclusion criteria were applied. The most common exclusion criteria include co‐morbidities, such as kidney and hepatic disease, severe obesity or medication (antibiotics, steroids), which may influence the results. Other criteria mentioned were emergency surgery (<a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>), palliative surgery (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>) or off‐pump surgery (<a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>), ketoacidosis (<a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>), history of hyperglycaemia (<a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>), pregnancy (<a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>), or imminent risk of death (<a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>). Three studies did not report exclusion criteria (<a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>). </p> </section> <section id="CD007315-sec-0067"> <h5 class="title">Diagnosis</h5> <p>Four of the 20 trials reported the diagnostic criterion for diabetes. The diagnosis in <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a> was made according to the American Diabetes Association (ADA) criteria and for <a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a> the WHO criteria were followed. <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a> reported that the diagnosis of diabetes was withdrawn from the report in the participants' medical history. <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a> confirmed newly diagnosed diabetes with a fasting blood glucose level equal to or greater than 200 mg/dL associated with an elevated glycosylated haemoglobin A1c (HbA1c). </p> </section> <section id="CD007315-sec-0068"> <h5 class="title">Interventions</h5> <p>In all studies, treatment in the intervention group aimed to achieve tight glycaemic control by intravenous insulin infusion. In one study target blood glucose was achieved by adjusting the glucose infusion while maintaining a fixed insulin infusion rate (<a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>). In the other studies, the target blood glucose was achieved by adjusting the insulin infusion rate. The control group was treated with an intravenous insulin infusion adapted to a higher glucose target (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a><a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>), or with boluses of subcutaneous insulin (<a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). </p> <p>In the study <a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a> the tight glucose control intervention was part of a factorial design with two additional arms, namely dexamethasone versus placebo and deep versus light anaesthesia. </p> <p>In studies that set a specific duration of the intervention, this ranged from a few hours to five days. In three studies the intervention happened during surgery in the operating room (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>), and in seven studies the intervention was performed during the ICU stay (<a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>). In seven studies the intervention started during surgery and was either extended to ICU (<a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>), or until extubation (<a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>) or discharge (<a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>). In one study the intervention began before surgery and was prolonged during surgery (<a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>), and in another study, the intervention was dispensed postoperatively (<a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). In one study the intervention began in the ICU and lasted until oral intake or enteral nutrition was established (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>). </p> </section> <section id="CD007315-sec-0069"> <h5 class="title">Outcomes</h5> <p>Eleven of the 20 included studies were registered in ClinicalTrials.gov (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>). In all of these trials, the outcomes defined in the publication showed consistency with the trial registration. In the publication of <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>, a registration number was provided, but it could not be found, possibly due to an error in some digit in the register. </p> <p>All the studies specified the primary outcome in the publication, except for <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a> and <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>, in which it was not clearly stated. In the case of secondary outcomes, these were not listed in these two studies, nor in <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a> and <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>. </p> <p>All‐cause mortality and infection were the most commonly defined primary outcomes in publications. All‐cause mortality was reported in 18 studies as a primary outcome (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). Infection complications were available in 18 studies (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). Most of the trials provided information on hypoglycaemic episodes, except three (<a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>). All‐cause mortality, infectious complications and hypoglycaemic episodes were well‐defined in all trials that collected these data, with the exception of <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>: while they provided the number of participants with hypoglycaemia, they did not specify the blood glucose values that defined it. </p> <p>Renal failure was available in 13 trials (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>), and cardiovascular events in 14 trials (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). Only two studies assessed weight gain (<a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>). Three studies reported the length of ICU stay (<a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>), four studies reported the length of hospital stay (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>), eight studies reported both ICU and hospital length of stay (<a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>), and five studies did not report information in this regard (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). With the exception of one trial (<a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>), the included trials reported on the mean blood glucose during the intervention. However, <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a> showed a figure with blood glucose concentrations but did not specify the data. Some of the included studies reported other complications within outcomes, such as neurological dysfunction (<a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>) or stroke (<a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>), prolonged mechanical ventilation (<a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>), respiratory failure (<a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>), delayed or loss graft function (<a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>), use of inotropic agent support (<a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>), mechanical circulatory support (<a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>), 30‐day readmission (<a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>) and, lastly, delayed gastric emptying, obstruction, bleeding, anastomotic leak and hepatic dysfunction (<a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). </p> <p>Outcomes for renal failure and length of stay (ICU and hospital) were well‐defined in the 13 trials. Mean blood glucose during intervention was well‐defined in most of the included trials (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>), however <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a> did not report the related date and, conversely, <a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a> and <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a> reported the data but did not provide specific outcome definition. Adverse events, other than hypoglycaemic episodes, were well‐defined in the outcomes of all included studies. </p> <p>Only one study, <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>, assessed quality of life using the Short Form‐12 questionnaire. However, these data were not included in the publication. We requested specific data from the author and incorporated these into the results. </p> <p>In the search results, we found a sub‐study (<a href="./references#CD007315-bbs2-0084" title="Saumeth Cardona, Francisco J pasquel, Maya Fayman, Limin Peng, Sol Jacobs, Priyathama Vellanki, Jef Weaver, Michael Halkos, Robert A Guyton, Vinod H Thouorani, Guillermo E Umpierrez. Hospitalization costs and clinical outcomes in CABG patients treated with intensive insulin therapy. Journal of Diabetes and its Complications 20 January 2017;31:742-747. [DOI: http://dx.doi.org/10.1016/j.jdiacomp.2017.01.003]">Cardona 2017</a>) with the same sample as <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a> (minus 14 participants who were excluded because of incomplete financial data), incorporating the economic data related to the participants' hospitalisation. </p> <p>The duration of follow‐up differed between included trials and depended on the outcome measurements. Therefore, the follow‐up ranged from discharge from the ICU (<a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>) to five years (<a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>). </p> <p>For more information on outcomes see <a href="./appendices#CD007315-sec-0119">Appendix 11</a>. </p> </section> </section> <section id="CD007315-sec-0070"> <h4 class="title">Ongoing trials</h4> <p>We found two ongoing RCTs (<a href="./references#CD007315-bbs2-0069" title="NCT02032953. Enhancing the anabolic effect of perioperative nutrition with insulin while maintaining normoglycemia. https://clinicaltrials.gov/ct2/show/NCT02032953 (first received 10 January 2014). ">NCT02032953</a>; <a href="./references#CD007315-bbs2-0070" title="NCT04742023. Post-operative complications and graft survival with conventional versus continuous glucose monitoring in patients with diabetes mellitus undergoing renal transplantation. https://clinicaltrials.gov/ct2/show/NCT04742023 (first received 5 February 2021). ">NCT04742023</a>). See <a href="./references#CD007315-sec-0141" title="">Characteristics of ongoing studies</a> for a detailed description. </p> </section> <section id="CD007315-sec-0071"> <h4 class="title">Excluded studies</h4> <p>We excluded 39 studies after evaluating the full text: six studies had the wrong study design (not RCTs); eight studies performed the intervention on participants who did not suffer from diabetes; 12 studies did not evaluate a more intensive glycaemic control versus moderate glycaemic control; two studies did not report on a perioperative intervention; 10 studies were excluded because separate data for participants with diabetes undergoing surgery were not obtained after contacting the authors, and two records were excluded because they were suspended trials. For further details see <a href="./references#CD007315-sec-0139" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD007315-sec-0072"> <h3 class="title">Risk of bias in included studies</h3> <p>The risk of bias assessment of the included trials is detailed in the <a href="./references#CD007315-sec-0138" title="">Characteristics of included studies</a> section. <a href="#CD007315-fig-0002">Figure 2</a> and <a href="#CD007315-fig-0003">Figure 3</a> provide an overview of judgements about each domain for individual trials and across all included trials. We discuss the details about the judgements specifically for each domain. </p> <div class="figure" id="CD007315-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials (blank cells indicate that the particular outcome was not measured in some trials)." data-id="CD007315-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials (blank cells indicate that the particular outcome was not measured in some trials). </p> </div> </div> </div> <div class="figure" id="CD007315-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included trial (blank cells indicate that the particular outcome was not measured in some trials)" data-id="CD007315-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included trial (blank cells indicate that the particular outcome was not measured in some trials) </p> </div> </div> </div> <section id="CD007315-sec-0073"> <h4 class="title">Allocation</h4> <p>We judged almost half of the included studies to be at low risk of selection bias (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>). Three studies described appropriate randomisation sequences but failed to describe how they ensured concealment (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>). </p> <p>The rest of the included trials did not provide enough details to judge their randomisation sequences. Six studies were simply described as randomised (<a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). Two used block randomisation but did not specify if it was permuted and, in consequence, allocation to the blocks may be predictable (<a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>). Finally, a trial used randomisation sequences that were susceptible to manipulation (<a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>). </p> </section> <section id="CD007315-sec-0074"> <h4 class="title">Blinding</h4> <p>Regarding performance bias, all‐cause mortality, cardiovascular events and renal failure were outcomes unlikely influenced by lack of blinding. On the other hand, the rest of the outcomes (hypoglycaemic events and other major complications, length of stay and mean blood glucose) may be influenced by lack of blinding, and we judged studies to be at high risk of performance bias as it was not feasible to blind the intervention and, in consequence, the trials were open for participants and trial personnel. </p> <p>Only six studies blinded the measurement of outcomes and were at low risk of detection bias (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>). The rest did not blind the outcome assessor (<a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>), or did not provide details (<a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>), and, in consequence, we judged them to be at high risk of detection bias. </p> </section> <section id="CD007315-sec-0075"> <h4 class="title">Incomplete outcome data</h4> <p>We judged 14 trials at low risk of attrition bias (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). </p> <p>Two trials did not recruit the number of participants to reach the sample size calculated (<a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>), one trial modified the planned enrolment (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>), and one did not report details on the analyses to deal with this issue. </p> <p>We judged a further three trials to be at unclear risk of attrition bias. <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a> described cross‐over between treatment arms (approximately for 20% of randomised participants), which led to a per‐protocol analysis. <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a> stopped the study prematurely due to the high rate of unintended protocol violations. <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a> reported many protocol deviations and cross‐over between groups that were excluded from final analyses. </p> </section> <section id="CD007315-sec-0076"> <h4 class="title">Selective reporting</h4> <p>We categorised the risk of outcome reporting bias according to the Outcome Reporting Bias In Trials (ORBIT) classification (<a href="./appendices#CD007315-sec-0118">Appendix 10</a>). We suspected that three trials likely assessed the hypoglycaemic episodes but did not report results regarding this outcome (<a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>). An additional trial disclosed mortality as the primary outcome in its registration record but reported the results as a secondary outcome (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>). </p> <p>Ten trials reported insufficient information on registration or the outcomes assessed to judge if they were biased in this domain (<a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). These trials reported results for all the outcomes described in the methods section. </p> </section> <section id="CD007315-sec-0077"> <h4 class="title">Other potential sources of bias</h4> <p>We did not identify any other source of bias that could impact the internal validity of the included trials. </p> </section> </section> <section id="CD007315-sec-0078"> <h3 class="title" id="CD007315-sec-0078">Effects of interventions</h3> <p>See: <a href="./full#CD007315-tbl-0001"><b>Summary of findings 1</b> Summary of findings: perioperative control for people with diabetes undergoing surgery</a> </p> <p>See <a href="./full#CD007315-tbl-0001">summary of findings Table 1</a>. </p> <section id="CD007315-sec-0079"> <h4 class="title">Baseline characteristics</h4> <p>For details of baseline characteristics, see <a href="./appendices#CD007315-sec-0115">Appendix 7</a> and <a href="./appendices#CD007315-sec-0116">Appendix 8</a>. </p> </section> <section id="CD007315-sec-0080"> <h4 class="title">Perioperative intensive glycaemic control versus conventional glycaemic control</h4> <section id="CD007315-sec-0081"> <h5 class="title">Primary outcomes</h5> <section id="CD007315-sec-0082"> <h6 class="title">All‐cause mortality</h6> <p>Twelve of the studies included measured all‐cause mortality as a primary outcome (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>); two trials reported death from any cause as a secondary outcome (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>), and four included studies reported this outcome in their study (<a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>). </p> <p>Intensive glycaemic control resulted in little or no difference in all‐cause mortality compared to the conventional glycaemic control (130/1263 (10.3%) and 117/1288 (9.1%) events, respectively, risk ratio (RR) 1.08, 95% confidence interval (CI) 0.88 to 1.33; I<sup>2</sup> = 0%; 2551 participants, 18 studies; <a href="./references#CD007315-fig-0011" title="">Analysis 1.1</a>). We did not identify noticeable asymmetry in the funnel plot (<a href="#CD007315-fig-0004">Figure 4</a>). The certainty of the evidence for this outcome was high. </p> <div class="figure" id="CD007315-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="original image" data-id="CD007315-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> <section id="CD007315-sec-0083"> <h6 class="title">Hypoglycaemic episodes</h6> <p>Seventeen studies reported the number of participants with measured hypoglycaemic episodes (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>), and 11 studies provided measurement of severe hypoglycaemic episodes (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). </p> <p>Intensive glycaemic control may slightly increase severe hypoglycaemic episodes compared to the conventional treatment group (37/927 (4%) and 6/969 (0.6%) events, respectively, RR 4.73, 95% CI 2.12 to 10.55; I<sup>2</sup> = 0%; 1896 participants, 11 studies; <a href="./references#CD007315-fig-0013" title="">Analysis 1.3</a>). The certainty of the evidence is low due to risk of bias and imprecision. </p> <p>Intensive glycaemic control resulted in a slight increase in hypoglycaemic episodes compared to conventional care (141/1184 (11.9%) and 41/1226 (3.3%) events, respectively, RR 3.36, 95% CI 1.69 to 6.67; I<sup>2</sup> = 64%; 2410 participants, 17 studies; <a href="./references#CD007315-fig-0014" title="">Analysis 1.4</a>). The certainty of the evidence is low due to risk of bias and inconsistency. We did not identify noticeable asymmetry in the funnel plot (<a href="#CD007315-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD007315-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="original image" data-id="CD007315-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> <section id="CD007315-sec-0084"> <h6 class="title">Infectious complications</h6> <p>A total of 18 trials included infection as one of their outcomes (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). </p> <p>Intensive glycaemic control may result in little to no difference in the rate of infectious complications compared to conventional glycaemic control (160/1228 (13%) and 224/1225 (18.3%) events, respectively, RR 0.75, 95% CI 0.55 to 1.04; I<sup>2</sup> = 55%; 2453 participants, 18 studies; <a href="./references#CD007315-fig-0017" title="">Analysis 1.7</a>). The certainty of the evidence is low due to risk of bias and inconsistency. We did not identify noticeable asymmetry in the funnel plot (<a href="#CD007315-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD007315-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="original image" data-id="CD007315-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-06.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> </section> <section id="CD007315-sec-0085"> <h5 class="title">Secondary outcomes</h5> <section id="CD007315-sec-0086"> <h6 class="title">Cardiovascular events</h6> <p>Twelve studies reported cardiovascular events (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). </p> <p>Intensive glycaemic control may result in a decrease in cardiovascular events compared to the conventional treatment group (127/729 (17.4%) and 117/725 (24.4%) events, respectively, RR 0.73, 95% CI 0.55 to 0.97; I<sup>2</sup> = 44%; 1454 participants, 12 studies; <a href="./references#CD007315-fig-0019" title="">Analysis 1.9</a>). The certainty of the evidence is low due to risk of bias and imprecision. We did not identify noticeable asymmetry in the funnel plot (<a href="#CD007315-fig-0007">Figure 7</a>). </p> <div class="figure" id="CD007315-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="original image" data-id="CD007315-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-07.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> <section id="CD007315-sec-0087"> <h6 class="title">Renal failure</h6> <p>A total of 14 studies included renal failure as an outcome in their trials (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). Various definitions were used for renal failure (<a href="./appendices#CD007315-sec-0119">Appendix 11</a>), mostly depending on creatine levels or the need for dialysis. </p> <p>Intensive glycaemic control may result in little or no difference in the number of renal failure events compared to the conventional treatment group (137/1029 (13.3%) and 158/1057 (14.9%) events, respectively, RR 0.92, 95% CI 0.69 to 1.22; I<sup>2</sup> = 38%; 2086 participants, 14 studies; <a href="./references#CD007315-fig-0021" title="">Analysis 1.11</a>). We did not identify noticeable asymmetry in the funnel plot (<a href="#CD007315-fig-0008">Figure 8</a>). The certainty of the evidence is low due to indirectness and imprecision. </p> <div class="figure" id="CD007315-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="original image" data-id="CD007315-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-08.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> <section id="CD007315-sec-0088"> <h6 class="title">Length of ICU</h6> <p>Data on the length of ICU stay were available from 11 studies (<a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>). </p> <p>Intensive glycaemic control likely results in little to no difference in the number of days in the ICU compared to the control group (mean difference (MD) ‐0.10 days, 95% CI ‐0.57 to 0.38; P = 0.69; I<sup>2</sup> = 69%; 1687 participants, 11 studies; <a href="./references#CD007315-fig-0023" title="">Analysis 1.13</a>). The certainty of the evidence is low due to inconsistency and risk of bias. We did not identify noticeable asymmetry in the funnel plot (<a href="#CD007315-fig-0009">Figure 9</a>). </p> <div class="figure" id="CD007315-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="original image" data-id="CD007315-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-09.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> <section id="CD007315-sec-0089"> <h6 class="title">Length of hospital stay</h6> <p>Data on the total length of hospital stay were provided by 12 studies (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>). </p> <p>Intensive glycaemic control may result in little to no difference in the mean length of hospital stay compared to the control group, but the evidence is very uncertain (MD ‐0.79 days, 95% CI ‐1.79 to 0.21; I<sup>2</sup> = 77%; 1520 participants, 12 studies; <a href="./references#CD007315-fig-0025" title="">Analysis 1.15</a>). The certainty of the evidence is very low due to risk of bias, inconsistency and imprecision. We did not identify noticeable asymmetry in the funnel plot (<a href="#CD007315-fig-0010">Figure 10</a>). </p> <div class="figure" id="CD007315-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="original image" data-id="CD007315-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-10.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> <section id="CD007315-sec-0090"> <h6 class="title">Mean blood glucose during intervention</h6> <p>Mean blood glucose during intervention was available from 17 studies (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). One study could not be included in the analysis due to missing SD values (<a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>). We obtained data on mean blood glucose during the intervention from one study by approximating mean values at zero and six hours from the figure and the SD from the reported standard error of the mean. We assumed the SD values at 0 and 6 hours in the ICU (not reported) to be approximately equal to the associated time value. We estimated overall mean and SD values in each group by the pooled value computed from the five measures (<a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>). In another trial, we obtained data on mean glucose during the intervention by the pooled value computed from the two measures (values at the end of cardiopulmonary bypass and at 18 hours) (<a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>). In one study we obtained the pooled SD per day from the mean and P value, assuming equal variances in both groups, and we estimated the overall mean and SD values by the pooled value computed from the five days (<a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>). In another study, we estimated the overall mean by averaging the approximated values obtained from the graphical evolution of glucose levels during interventions. Overall SD was assumed to be comparable to the baseline glucose SD (<a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>). The studies showed important differences regarding this outcome and, in consequence, we could not combine the individual results in a meta‐analysis. Within the included studies, intensive glycaemic control resulted in the reduction of mean blood glucose with a mean lowering of blood glucose effect ranging from 13.42 mg/dL to 91.30 mg/dL. </p> </section> <section id="CD007315-sec-0091"> <h6 class="title">Health‐related quality of life</h6> <p>Only one study assessed health‐related quality of life with the SF‐12 norm‐based physical component score (<a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>). This means that a physical health composite score is composed using the scores of the 12 questions of the questionnaire that range from 0 to 100, indicating the lowest and the highest level of health, respectively. This composite score was compared to a national norm, such as a mean score of 50 (SD 10). In the intervention group the mean value of the physical health component score was 45 (SD 13) and in the control group 48 (SD 9). These data were available from only 12/37 (32.4%) participants in the intervention group and 13/44 (29.5%) participants in the control group. </p> </section> <section id="CD007315-sec-0092"> <h6 class="title">Socioeconomic effects</h6> <p>The <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a> study population is the only one for which socioeconomic data were available through the publication of a specific sub‐study by <a href="./references#CD007315-bbs2-0084" title="Saumeth Cardona, Francisco J pasquel, Maya Fayman, Limin Peng, Sol Jacobs, Priyathama Vellanki, Jef Weaver, Michael Halkos, Robert A Guyton, Vinod H Thouorani, Guillermo E Umpierrez. Hospitalization costs and clinical outcomes in CABG patients treated with intensive insulin therapy. Journal of Diabetes and its Complications 20 January 2017;31:742-747. [DOI: http://dx.doi.org/10.1016/j.jdiacomp.2017.01.003]">Cardona 2017</a>. </p> <p>In this post hoc cost analysis, the hospitalisation costs, utilisation of resources and perioperative complications were described for a total of 143 participants with diabetes, 72 and 71 participants in the conventional and intensive glycaemic control group, respectively. Costs by category and cost differences between the treatment arms were calculated. Hospital costs and utilisation of resources included pharmacy, radiology, laboratory, consultations and ICU costs. The adjustment ratios were determined from the Medicare Hospital Cost Report published by the Centers of Medicare and Medicaid Services and data available from the participating hospitals. The data were expressed in USD dollars with a mean (min‐max). </p> <p>The total hospital costs were higher in the conventional glycaemic control group, 42,052 USD (32,858 to 56,421), compared to the intensive glycaemic control group, 40,884 USD (31.216 to 49,992). The utilisation of resources was also higher in the conventional glycaemic control group (2138 USD (1711 to 2968)) compared to the group with intensive glycaemic control (1911 USD (1569 to 2773)). However, these differences in costs between conventional and intensive glycaemic control groups were not statistically significant for hospital costs (P = 0.18) or resource utilisation (P = 0.26). </p> </section> <section id="CD007315-sec-0093"> <h6 class="title">Weight gain</h6> <p>Only two studies provided data on weight gain. In one study, the weight gain was 11.0 kg (SD 7.5) in the intervention group and 10.6 kg (SD 5.8) in the control group (<a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>). The other study reported the mean maximum weight gain, which was 3.1 kg (SD 0.2) in the intervention group and 6.0 kg (SD 0.4) in the control group (<a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>). </p> </section> </section> </section> <section id="CD007315-sec-0094"> <h4 class="title">Sensitivity analyses</h4> <p>To assess the impact of risk of bias on the certainty of the evidence for all‐cause mortality, we performed a sensitivity analysis eliminating trials with an unclear risk of selection bias. Pooled data from eight trials with a low risk of selection bias (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>) showed a similar effect to when we assessed the whole set of included trials, with a RR of 1.09 (95% CI 0.88 to 1.36; I² = 0%; 1421 participants, 8 studies; high certainty of evidence; <a href="./references#CD007315-fig-0012" title="">Analysis 1.2</a>). </p> <p>We also performed sensitivity analyses restricted to data published in the reports of the included trials, with similar results to those in the main analyses. </p> <p>Sensitivity analysis restricted to published data for all‐cause mortality showed a RR of 0.76 in favour of intensive glycaemic control (95% CI 0.34 to 1.72; I² = 0%; 7 studies, 820 participants; high certainty of evidence; <a href="./references#CD007315-fig-0012" title="">Analysis 1.2</a>). The primary authors from seven trials provided data (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). </p> <p>Sensitivity analysis restricted to published data for severe hypoglycaemic events included three studies (<a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>). Excluding <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a> from the pooled analysis due to reporting zero events in both the intervention and control group, analysis of the two remaining trials showed a RR of 1.59 (95% CI 0.05 to 52.32; I² = 73%; 365 participants; low certainty of evidence; <a href="./references#CD007315-fig-0015" title="">Analysis 1.5</a>). For any hypoglycaemic events, sensitivity analysis included seven studies (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>), and resulted in a pooled RR of 2.24 (95% CI 0.56 to 8.94; I² = 68% ; 834 participants; low certainty of evidence; <a href="./references#CD007315-fig-0016" title="">Analysis 1.6</a>). </p> <p>For infectious complications, sensitivity analysis restricted to published data showed a RR of 0.54 (95% CI 0.38 to 0.75; I² = 24%; 9 studies, 1001 participants; low certainty of evidence; <a href="./references#CD007315-fig-0018" title="">Analysis 1.8</a>). </p> <p>Sensitivity analysis restricted to published data for cardiovascular events resulted in a RR of 0.80 (95% CI 0.50 to 1.25; I² = 50%; 6 studies, 727 participants; moderate certainty of evidence; <a href="./references#CD007315-fig-0020" title="">Analysis 1.10</a>). </p> <p>Sensitivity analysis for renal failure restricted to published data (<a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>) showed a RR of 0.79 (95% CI 0.42 to 1.45; I² = 47%; 5 trials, 559 participants; <a href="./references#CD007315-fig-0022" title="">Analysis 1.12</a>). </p> <p>Sensitivity analysis restricted to published data for the length of ICU stay (<a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>) resulted in a MD of 0.18 days (95% CI ‐0.07 to 0.43; I² = 0%; 3 trials, 248 participants; <a href="./references#CD007315-fig-0024" title="">Analysis 1.14</a>) </p> <p>Sensitivity analysis restricted to published data for hospital stay (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>) showed evidence of a reduction of hospital stay in favour of the intensive treatment group (MD ‐1.09 days, 95% CI ‐1.82 to ‐0.35; I² = 10%; 4 trials, 394 participants; low certainty of evidence; <a href="./references#CD007315-fig-0026" title="">Analysis 1.16</a>). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007315-sec-0095" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007315-sec-0095"></div> <section id="CD007315-sec-0096"> <h3 class="title" id="CD007315-sec-0096">Summary of main results</h3> <p>This review update aimed to investigate the effects of intensive perioperative glycaemic control versus conventional glycaemic control in people with diabetes mellitus. A total of 20 randomised controlled trials and two potentially relevant ongoing trials met the inclusion criteria. The review included studies on 2670 participants with diabetes, 1320 allocated to intensive perioperative glycaemic control and 1350 to conventional glycaemic control. </p> <p>We were able to demonstrate that intensive glycaemic control may decrease the occurrence of cardiovascular events. This beneficial effect was accompanied by a slight increase in the number of individuals experiencing hypoglycaemic and severe hypoglycaemic episodes in the intensive glycaemic control group. However, we should point out that moderate statistical heterogeneity between studies was present for these outcomes. Overall, we should underline that heterogeneity among studies was present for several outcomes. Additionally, there was heterogeneity regarding the methodology in the design of the intervention, the definition of intensive glycaemic control, and the definition and assessment of study variables (e.g. hypoglycaemia, infection and renal failure). </p> <p>The outcome of all‐cause mortality was the only one considered to have a high certainty of evidence. We judged the other outcomes to have low‐ or very low‐certainty evidence, and all trials had an unclear or high risk of bias in several of the risk of bias domains. </p> <p>We could not demonstrate that the intervention led to any clear reductions on important endpoints, such as all‐cause mortality, infectious complications and renal failure. Furthermore, no relevant effects were observed on the length of hospital stay. </p> <p>Considering the socioeconomic effects, we included data from a sub‐study on the same population from an included study in this review. Data showed positive effects, but no firm conclusions could be drawn. </p> </section> <section id="CD007315-sec-0097"> <h3 class="title" id="CD007315-sec-0097">Overall completeness and applicability of evidence</h3> <p>We performed an extensive search for trials, included publications in any language and placed no restrictions on the outcomes included in the trials. Where needed we tried to obtain additional information. The trials were conducted in five different continents with a large preponderance of studies performed in the USA. Most of the included trials did not define the diagnostic criteria for diabetes mellitus and also few trials provided information about the duration of diabetes of the participants. </p> <p>The participants included in these trials may not be representative of the general population of people with diabetes. We should point out that 11 studies included participants undergoing cardiovascular surgical interventions (<a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>). Also, it should be kept in mind that, in most trials, participants with the most severe surgical or pre‐surgical conditions were excluded. All these issues preclude the generalisation of the currently available results to many other patients with diabetes or for many types of surgical procedures that have not been included in this review. </p> <p>Nine studies exclusively included participants with diabetes (<a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a>; <a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a>; <a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a>; <a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>; <a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a>), while the other studies included both patients with and without diabetes (<a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a>; <a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a>; <a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a>; <a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a>; <a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a>; <a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a>; <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a>; <a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a>; <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a>; <a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a>; <a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a>) and, when applicable, we contacted the authors to obtain separate data on patients with diabetes. We had to exclude some potentially relevant studies because, despite contacting the authors, we were not provided with specific data for the subgroup of participants with diabetes mellitus undergoing surgery (<a href="./references#CD007315-bbs2-0071" title="AbdelmalakB , MaheshwariA , KovaciB , MarschaEJ , CywinskiJB , KurzA , et al. Validation of the DeLIT Trial intravenous insulin infusion algorithm for intraoperative glucose control in noncardiac surgery: a randomized controlled trial.. Canadian Journal of Anaesthesia2011;58(7):606-16.. [DOI: 10.1007/s12630-011-9509-3]">Abdelmalak 2011</a>; <a href="./references#CD007315-bbs2-0021" title="AbdelmalakBB , YouJ , KurzA , KotM , BralliarT , RemziFH , et al. The effects of dexamethasone, light anesthesia, and tight glucose control on postoperative fatigue and quality of life after major noncardiac surgery: a randomized trial. Journal of Clinical Anesthesia2019;55:83-91. [DOI: https://doi.org/10.1016/j.jclinane.2018.12.038]">Abdelmalak 2019</a>; <a href="./references#CD007315-bbs2-0076" title="AlbackerT , CarvalhoG , SchrickerT , Lachapelle K. High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass graTing patients.. Annals of Thoracic Surgery2008;86(1):20-7. [DOI: 10.1016/j.athoracsur.2008.03.046]">Albacker 2008</a>; <a href="./references#CD007315-bbs2-0079" title="Yaseen M Arabi, Ousama C Dabbagh, Hani M Tamim, Abdullah A Al-Shimemeri, Ziad A Memish, Samir H Haddad, Sofia J Syed, Hema R Giridhar, Asgar H Rishu, Mouhamad O Al-Daker, Salim H Kahoul, Riette J Britts, Maram H Sakkijha. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Critical Care Medicine December 2008;36(12):3190-7. [DOI: 0.1097/CCM.0b013e31818f21aa]">Arabi 2008</a>; <a href="./references#CD007315-bbs2-0081" title="BilottaF , CaramiaR , PaoloniFP , DelfiniR , RosaG . Safety and efficacy of intensive insulin therapy in critical neurosurgical patients.. Anesthesiology2009;110(3):611-9. [DOI: 10.1097/ALN.0b013e318198004b]">Bilotta 2009</a>; <a href="./references#CD007315-bbs2-0085" title="George Carvalho, Patricia Pelletier, Turki Albacker, Kevin Lachapelle, Denis R Joanisse, Roupen Hatzakorzian, Ralph Lattermann, Hiroaki Sato, André Marette, Thomas Schricker. Cardioprotective effects of glucose and insulin administration while maintaining normoglycemia (GIN therapy) in patients undergoing coronary artery bypass grafting. The Journal of Clinical Endocrinology &amp; Metabolism May 2011;96(5):1469-77. [DOI: 10.1210/jc.2010-1934.]">Carvalho 2011</a>; <a href="./references#CD007315-bbs2-0030" title="GiakoumidakisK , EltheniR , PatelarouE , TheologouS , PatrisV , MichopanouN , et al. Effects of intensive glycemic control on outcomes of cardiac surgery. Heart and Lung2013;42(2):146-51. ">Giakoumidakis 2013</a>; <a href="./references#CD007315-bbs2-0095" title="HeW , ZhangTY , ZhouH , LiT , ZhaoJY , ZhaoD , et al. Impact of intensive insulin therapy on surgical critically ill patients. Chinese Journal of Surgery2007;45(15):1052-4. [PMID: 18005588]">He 2007</a>; <a href="./references#CD007315-bbs2-0034" title="KalfonP , GiraudeauB , IchaiC , GuerriniA , BrechotN , CinottiR , et al, Group, Cgao-Rea Study. Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial. Intensive Care Medicine2014;40(1):171-81. ">Kalfon 2014</a>; <a href="./references#CD007315-bbs2-0036" title="KumarSS , PelletierSJ , ShanksA , ThompsonA , SonnendayCJ , PictonP . Intraoperative glycemic control in patients undergoing Orthotopic liver transplant: a single center prospective randomized study. BMC Anesthesiology2020;20(3):1-11. [DOI: https://doi.org/10.1186/s12871-019-0918-0]">Kumar 2020</a>; <a href="./references#CD007315-bbs2-0037" title="KurnazP , SungurZ , CamciE , SivrikozN , OrhunG , SenturkM , et al. The effect of two different glycemic management protocols on postoperative cognitive dysfunction in coronary artery bypass surgery. Revista Brasileira de Anestesiologia2017;67(3):258-65. ">Kurnaz 2017</a>; <a href="./references#CD007315-bbs2-0115" title="Imogen Mitchell, Emma Knight, Jelena Gissane, Rohit Tamhane, Rao Kolli, I Anne Leditschke, Rinaldo Bellomo, Simon Finfer, Australian and New Zealand Intensive Care Society Clinical Trials Group. A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients. Critical Care Resuscitation December 2006 ;8(4):289-93. [PMID: 17227263]">Mitchell 2006</a>; <a href="./references#CD007315-bbs2-0042" title="MohodV , GaneriwalV , BhangeJ . Comparison of intensive insulin therapy and conventional glucose management in patients undergoing coronary artery bypass grafting. Journal of Anesthesiology, Clinical Pharmacology2019;35(4):493-7. [PMID: 31920233]">Mohod 2019</a>; <a href="./references#CD007315-bbs2-0047" title="OkabayashiT , ShimaY , SumiyoshiT , KozukiA , TokumaruT , LiyamaT , et al. Intensive versus intermediate glucose control in surgical intensive care unit patients. Diabetes Care2014;37(6):1516-24. ">Okabayashi 2014</a>; <a href="./references#CD007315-bbs2-0054" title="RujirojindakulP , LiabsuetrakulT , McNeilE , ChanchayanonT , WasinwongW , OofuvongM , et al. Safety and efficacy of intensive intraoperative glycaemic control in cardiopulmonary bypass surgery: a randomised trial. Acta Anaesthesiologica Scandinavica2014;58(5):588-96. ">Rujirojindakul 2014</a>; <a href="./references#CD007315-bbs2-0055" title="Eduesley Santana-Santos, Patricia Hatanaka Kanke, Rita de Cássia Almeida Vieira, Larissa Bertacchini de Oliveira, Renata Eloah de Lucena Ferretti-Rebustin, et al. Impact of intensive glycemic control on acute renal injury: a randomized clinical trial. Acta Paul Enferm2019;32(6):592-9. [DOI: http://dx.doi.org/10.1590/1982-0194201900083]">Santana‐Santos 2019</a>; <a href="./references#CD007315-bbs2-0126" title="WangQG , LuLF , ZhouYB , CaoSG , WangDS , Lv L. Effects of intensive insulin therapy on insulin resistance and serum proteins aTer radical gastrectomy.. Chinese Journal of Gastrointestinal Surgery2008;11(5):444-7. [PMID: 18803046]">Wang 2008</a>). Therefore, potentially available relevant information stemming from participants in other RCTs is missing from this review. </p> <p>The target blood glucose concentrations and the regimens used in the intensive study groups differed among trials. Further, the duration and time of initiation of interventions were also different. Therefore, the available information from trials does not allow the establishment of an optimal glycaemic target, an optimal treatment regimen or an adequate duration of the perioperative intervention. </p> <p>Finally, the review deals with a heterogeneous group of studies. Our meta‐analyses were limited by the inability to use individual participant data to assess whether distinct clinical characteristics may have influenced the effect estimates of the intervention. Although the analysis shows homogeneity only for all‐cause mortality and length of ICU stay, we have determined to include all outcomes in the meta‐analysis in order to explore the data and gain further insights in the review. The reader should take into account this heterogeneity in interpreting the results. </p> </section> <section id="CD007315-sec-0098"> <h3 class="title" id="CD007315-sec-0098">Quality of the evidence</h3> <p>None of the included studies was classified as having a low risk of bias in all the assessed domains. Concerning the design of the trials, it was not feasible to establish double‐blinding of investigators and participants. This may have influenced the performance of investigators, especially in relation to the hypoglycaemic episodes and assessment of infection. For this reason, we judged most trials to be at high risk of performance bias for these outcomes. On the other hand, we considered the blinding of outcome assessment to be of low or uncertain risk of bias for most variables. This can be considered a lesser concern as all reported outcomes were not subject to individual interpretation. Additionally, many trials had an unclear risk of bias for randomisation and allocation concealment. </p> <p>The major reasons for downgrading the certainty of the evidence were the impact of the risk of bias (mainly the lack of blinding), inconsistency (due to unexplained statistical heterogeneity within effect estimates from trials included), or imprecision. As a result of this assessment, we were confident about the estimates of effect for all‐cause mortality but not for the other outcomes, which had problems related to the risk of bias, severe inconsistency and imprecision. </p> </section> <section id="CD007315-sec-0099"> <h3 class="title" id="CD007315-sec-0099">Potential biases in the review process</h3> <p>As part of this update, we contacted the authors of the eligible trials to request possible missing data, clarification and separate data on participants with diabetes undergoing surgery if necessary. Some authors were not contacted because all information was available in the published article. A total of 12 trials (<a href="./appendices#CD007315-sec-0125">Appendix 17</a>) could not be included because the authors did not provide outcome data for a subpopulation of patients with diabetes, and a large amount of possible additional information could not be captured. Additionally, we identified two ongoing studies. </p> <p>The design of the intervention and the glycaemic targets also varied substantially between trials. Further, the definitions of the trial outcomes varied among trials, and some of the trials did not include data on relevant outcomes such as hypoglycaemic events or infectious complications. </p> </section> <section id="CD007315-sec-0100"> <h3 class="title" id="CD007315-sec-0100">Agreements and disagreements with other studies or reviews</h3> <p>The present review is an update of a previously published systematic review (<a href="./references#CD007315-bbs2-0131" title="BuchleitnerAM , Martínez-AlonsoM , HernándezM , SolàI , MauricioD . Perioperative glycaemic control for diabetic patients undergoing surgery. Cochrane Database of Systematic Reviews 29 February 2012, Issue 9. Art. No: CD007315. [DOI: 10.1002/14651858.CD007315.pub2]">Buchleitner 2012</a>). The addition of eight new studies in this updated review yielded different and relevant insights, including a decrease in infection rates in participants under intensive perioperative blood glucose control. </p> <p>Other reviews on strict blood glucose control in the perioperative period have been published. The most recent systematic review dealt with patients with diabetes undergoing cardiac surgery (<a href="./references#CD007315-bbs2-0105" title="JinX , WangJ , MaY , LiX , AnP , WangJ , MaoW , MuY , ChenY , ChenK . Association between Perioperative Glycemic control strategy and mortality in patients with diabetes undergoing cardiac surgery: A Systematic review and Meta-Analysis. Front Endocrinol December 2020;17:513-573.">Jin 2020</a>). Its main conclusion was that intensive blood glucose control is associated with a lower risk of atrial fibrillation and sternal wound infection. This review included six RCTs, three of which were also assessed in the present review (<a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>; <a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a>). One of the other three included studies was considered to be awaiting classification in our review (<a href="./references#CD007315-bbs2-0068" title="ZadehFJ , AzematiS . Adjusted tight control blood glucose management in diabetic patients undergoing on pump coronary artery bypass graft. A randomized clinical trial. Journal of Diabetes &amp; Metabolic Disorders2020;1:1-8. [DOI: https://doi.org/10.1007/s40200-020-00494-4]ZadehFJ , Ghazi NourM . A study on the outcomes of modified tight glucose control for the management of glycemic control in diabetic patients undergoing cardiac surgery. Journal of Pharmacy Research2016;10(11):764-70. ">Zadeh 2016</a>). The other two studies were excluded from this review due to methodological concerns or not fulfilling the criteria for inclusion in the current review (<a href="./references#CD007315-bbs2-0024" title="AsidaSM , AtallaMMM , GadGS , AisaKM , Mohamed Hs. Effect of perioperative control of blood glucose level patient’s outcome after anesthesia for cardiac surgery. Egyptian Journal of Anaesthesia2013;29:71-6. ">Asida 2013</a>; <a href="./references#CD007315-bbs2-0108" title="KirdemirP , YildirimV , KirisI , GulmenS , KuralayE , IbrisimE , et al. Does continuous insulin therapy reduce postoperative supraventricular tachycardia incidence after coronary artery bypass operations in diabetic patients. Journal of Cardiothorac Vascular Anesthesia2008;22:383-387.">Kirdemir 2008</a>). </p> <p>Another recent meta‐analysis dealt with patients with and without diabetes (<a href="./references#CD007315-bbs2-0107" title="KangZQ , HuoJL , ZhaiXJ . Effects of perioperative tight glycaemic control on postoperative outcomes: a meta-analysis. Endocr Connect. 1 December 2018;12:316-327.">Kang 2018</a>), and its main conclusion was that compared to liberal control, perioperative tight glucose control was associated with a significant reduction in short‐term mortality, cardiac surgery mortality, mortality in patients with diabetes and certain postoperative complications (acute kidney injury, sepsis, surgical site infection, atrial fibrillation). </p> <p>From a clinical point of view, the burden of the potentially associated late complications of diabetes in participants with diabetes mellitus puts these people at a clearly different baseline risk of intra‐ and postoperative morbidity and mortality as compared with participants without diabetes mellitus. Therefore, we strongly believe that trials addressing the main question of the current review should be designed exclusively for participants with diabetes and that systematic reviews should clearly differentiate between participants with and without diabetes. </p> <p>Finally, the review by Sathya et al in patients with diabetes and under different targets for blood glucose during the perioperative period concluded that a moderately intensive perioperative glycaemic target (150 mg/dL to 200 mg/dL (5.6 mmol/L to 8.3 mmol/L)) was associated with a reduction in postoperative mortality and stroke compared with a liberal target (<a href="./references#CD007315-bbs2-0119" title="SathyaB , DavisR , TaveiraT , WhitlatchH , WuWC . Intensity of peri-operative glycaemic control and postoperative outcomes in patients with diabetes: a meta-analysis. Diabetes Res Clin Pract October 2013;102:8-15.">Sathya 2013</a>). Of the studies included in this review, only three were RCTs (<a href="./references#CD007315-bbs2-0108" title="KirdemirP , YildirimV , KirisI , GulmenS , KuralayE , IbrisimE , et al. Does continuous insulin therapy reduce postoperative supraventricular tachycardia incidence after coronary artery bypass operations in diabetic patients. Journal of Cardiothorac Vascular Anesthesia2008;22:383-387.">Kirdemir 2008</a>; <a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a>; <a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a>). The reviews by Kang (<a href="./references#CD007315-bbs2-0107" title="KangZQ , HuoJL , ZhaiXJ . Effects of perioperative tight glycaemic control on postoperative outcomes: a meta-analysis. Endocr Connect. 1 December 2018;12:316-327.">Kang 2018</a>) and Sathya (<a href="./references#CD007315-bbs2-0119" title="SathyaB , DavisR , TaveiraT , WhitlatchH , WuWC . Intensity of peri-operative glycaemic control and postoperative outcomes in patients with diabetes: a meta-analysis. Diabetes Res Clin Pract October 2013;102:8-15.">Sathya 2013</a>) further reported an increased risk of hypoglycaemia with strict blood glucose strategies. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007315-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-FIG-01" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD007315-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials (blank cells indicate that the particular outcome was not measured in some trials)." data-id="CD007315-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials (blank cells indicate that the particular outcome was not measured in some trials). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included trial (blank cells indicate that the particular outcome was not measured in some trials)" data-id="CD007315-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included trial (blank cells indicate that the particular outcome was not measured in some trials) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-FIG-04" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD007315-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-FIG-05" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD007315-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-FIG-06" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD007315-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-FIG-07" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD007315-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-FIG-07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-FIG-08" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD007315-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-FIG-08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-FIG-09" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD007315-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-FIG-09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-FIG-10" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD007315-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-FIG-10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-FIG-10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 1: All‐cause mortality" data-id="CD007315-fig-0011" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 1: All‐cause mortality </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#CD007315-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 2: All‐cause mortality (sensitivity analysis: only published data; low risk of bias)" data-id="CD007315-fig-0012" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 2: All‐cause mortality (sensitivity analysis: only published data; low risk of bias) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#CD007315-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 3: Hypoglycaemic episodes (severe)" data-id="CD007315-fig-0013" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 3: Hypoglycaemic episodes (severe) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#CD007315-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 4: Hypoglycaemic episodes (any)" data-id="CD007315-fig-0014" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 4: Hypoglycaemic episodes (any) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#CD007315-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 5: Hypoglycaemic episodes (severe; sensitivity analysis: only published data)" data-id="CD007315-fig-0015" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 5: Hypoglycaemic episodes (severe; sensitivity analysis: only published data) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#CD007315-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 6: Hypoglycaemic episodes (any; sensitivity analysis: only published data)" data-id="CD007315-fig-0016" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 6: Hypoglycaemic episodes (any; sensitivity analysis: only published data) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#CD007315-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 7: Infectious complications" data-id="CD007315-fig-0017" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 7: Infectious complications </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#CD007315-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 8: Infectious complications (sensitivity analysis: only published data)" data-id="CD007315-fig-0018" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 8: Infectious complications (sensitivity analysis: only published data) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#CD007315-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 9: Cardiovascular events" data-id="CD007315-fig-0019" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 9: Cardiovascular events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#CD007315-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 10: Cardiovascular events (sensitivity analysis: only published data)" data-id="CD007315-fig-0020" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 10: Cardiovascular events (sensitivity analysis: only published data) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#CD007315-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 11: Renal failure" data-id="CD007315-fig-0021" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 11: Renal failure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#CD007315-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 12: Renal failure (sensitivity analysis: only published data)" data-id="CD007315-fig-0022" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 12: Renal failure (sensitivity analysis: only published data) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#CD007315-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 13: Length of ICU stay" data-id="CD007315-fig-0023" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 13: Length of ICU stay </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#CD007315-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 14: Length of ICU stay (sensitivity analysis: only published data)" data-id="CD007315-fig-0024" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 14: Length of ICU stay (sensitivity analysis: only published data) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#CD007315-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 15: Length of hospital stay" data-id="CD007315-fig-0025" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 15: Length of hospital stay </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#CD007315-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007315-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/urn:x-wiley:14651858:media:CD007315:CD007315-CMP-001.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 16: Length of hospital stay (sensitivity analysis: only published data)" data-id="CD007315-fig-0026" src="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_t/tCD007315-CMP-001.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1: Perioperative intensive vs conventional glycaemic control, Outcome 16: Length of hospital stay (sensitivity analysis: only published data) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#CD007315-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/media/CDSR/CD007315/image_n/nCD007315-CMP-001.16.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD007315-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings: perioperative control for people with diabetes undergoing surgery</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="bottom"> <p><b>Perioperative glycaemic control for people with diabetes undergoing surgery</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Patients:</b> people with diabetes undergoing surgery </p> <p><b>Settings:</b> hospital </p> <p><b>Intervention:</b> intensive blood glucose control </p> <p><b>Comparison:</b> conventional blood glucose control </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comment</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with conventional glucose control <sup>a</sup> </b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with intensive glucose control</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> <p>(death from any cause)</p> <p>Follow‐up: from 28 days to 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>91 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>98 per 1000</b> (80 to 121) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.08</b> (0.88 to 1.33) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2551 (18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>high</b><sup>b,c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The pooled relative effect was based on 15 studies; 3 studies could not be included as they had zero events in both the intervention and control groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Severe hypoglycaemic episodes</b> </p> <p>(number of severe hypoglycaemic episodes)</p> <p>Follow‐up: from 28 days to 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>6 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 1000</b> (13 to 65) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 4.73</b> (2.12 to 10.55) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1896 (11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>c,e,f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The pooled relative effect was based on 8 studies; 3 studies could not be included as they had zero events in both the intervention and control groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Infectious complications</b> </p> <p>(infectious complication after surgery (e.g. pneumonia, urinary tract infection))</p> <p>Follow‐up: from 28 days to 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>183 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>137 per 1000</b> (101 to 190) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.75</b> (0.55 to 1.04) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2453 (18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>low</b><sup>c,g,h</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The pooled relative effect was based on 16 studies; 2 studies could not be included as they had zero events in both the intervention and control groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cardiovascular events</b> </p> <p>(incidents that may cause damage to the cardiovascular system)</p> <p>Follow‐up: from 28 days to 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>244 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>178 per 1000</b> (134 to 237) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.73</b> (0.55 to 0.97) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1454 (12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>low</b><sup>c,h,i</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The pooled relative effect was based on 11 studies; one study could not be included as it had zero events in both the intervention and control groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Renal failure</b> </p> <p>(number of individuals with an elevation of serum creatinine greater than 2 mg/dL or requiring dialysis) </p> <p>Follow‐up: from 28 days to 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>149 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>138 per 1000</b> (103 to 182) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.92</b> (0.69 to 1.22) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2086 (14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>low</b><sup>c,g,j</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Length of ICU stay</b> </p> <p>(days admitted to the ICU unit)</p> <p>Follow‐up: from 28 days to 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of ICU stay ranged across control groups from 1.2 to 7.4 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of ICU stay in the intervention groups was <b>0.1 days shorter</b> (0.57 days shorter to 0.38 days longer) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1687 (11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝</p> <p><b>low</b><sup>h,k</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Length of hospital stay</b> </p> <p>(days admitted to the hospital)</p> <p>Follow‐up: from 28 days to 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay ranged across control groups from 5.0 to 19.6 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay in the intervention groups was <b>0.79 days shorter</b> (1.79 days shorter to 0.21 days longer) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1520 (12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>very low</b><sup>h,k,l</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>CI:</b> confidence interval; <b>ICU:</b> intensive care unit; <b>MD:</b> mean difference; <b>RR:</b> risk ratio </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>GRADE Working Group quality of evidence grades</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Mean baseline risk from the included studies. </p> <p><sup>b</sup>Not downgraded for risk of bias: studies with an unclear risk of selection bias did not have major impact on certainty. A sensitivity analysis omitting these studies showed a similar effect estimate (RR 1.09, 95% CI 0.88 to 1.36). </p> <p><sup>c</sup>Optimal information sizes are estimated to assess the precision of the effect estimates according to a threshold of an anticipated 25% relative risk reduction. </p> <p><sup>d</sup>Not downgraded for imprecision: according to the control group event rate (0.1) and an anticipated 25% relative risk reduction, the optimal information size has been reached. </p> <p><sup>e</sup>Downgraded by one level due to the impact of risk of bias: the trial informing the outcome was open for participants and personnel, and many did not provide details on blinding of outcome assessment. </p> <p><sup>f</sup>Downgraded by one level for imprecision: optimal information size probably not met; with a 0.05 control group event rate and an anticipated 25% relative risk reduction, about 3500 participants would be required. </p> <p><sup>g</sup>Downgraded by one level for imprecision: optimal information size probably not met; with a 0.10 control group event rate and an anticipated 25% relative risk reduction, about 3000 participants would be required. </p> <p><sup>h</sup>Downgraded by one level due to risk of bias: all included studies were at an overall high risk of bias. </p> <p><sup>i</sup>Downgraded by one level for imprecision: optimal information size probably not met; with a 0.10 control group event rate and an anticipated 25% relative risk reduction, about 2000 participants would be required. </p> <p><sup>j</sup>Downgraded by one level for indirectness: heterogeneous definition of the outcome measure. </p> <p><sup>k</sup>Downgraded by one level for inconsistency: unexplained statistical heterogeneity within effect estimates from trials informing this outcome (I<sup>2</sup> = 69% for length of ICU stay, I<sup>2</sup> = 77% for length of hospital stay) with large differences in point estimates. </p> <p><sup>l</sup>Downgraded by one level for imprecision: lower 95% CI boundary includes the possibility of an important benefit. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings: perioperative control for people with diabetes undergoing surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007315-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of study population (participants with diabetes undergoing surgery)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study (design)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention(s) and comparator(s)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Description of power and sample size calculation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Screened/eligible (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Randomised (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Analysed (primary outcome) (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Finishing trial (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Randomised finishing trial (%)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Follow‐up</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: hyperinsulinaemic normoglycaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>226*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>226*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>226*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Follow ‐up 30 months</p> <p>475 *</p> <p>Follow‐up 1 year: —</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>249*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>249*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>249*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>475*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>475*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>475*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100*</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive (140)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>1 year follow‐up: 49*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: moderate (180)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>49*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>49*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>49*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100*</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: tight glycaemic control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>30 days follow up: 135</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional moderate glycaemic control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>135</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>135</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>135</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a> </p> <p>Parallel‐group RCT</p> <p>Study terminated early</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: moderately intense control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>With power of 80% and a P value of 0.05 the sample size is 40 recipients per study group </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Follow up 30 days: 58 (97%)</p> <p>Follow up 6 months: 51 (83.3%)</p> <p>Follow up 1 year: 42 (70%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>60</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>60</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>60</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive glycaemic (IG) management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional glycaemic (CG) management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>212</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>212</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>210</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>99</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>152*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conservative group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>152*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>152*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>152*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100*</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a> </p> <p>Parallel‐group RCT</p> <p>Study terminated early</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive glucose management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 103*</p> <p>Follow up 1 year: 103*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional glucose management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign="top"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>103*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>103*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive glycaemic control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"The statistical error rates were established a priori at 0.15 and 0.20 for the type I and type II error rates, respectively. The sample size for the clinical trial was based on feasibility of enrollment along with power to detect a clinically relevant effect size in secondary endpoints (e.g. BG levels and biomarkers) at the P 0.15 level of significance. The upper bound for the recruitment potential of this single clinical site was based on transplant volume. The transplant center estimated approximately 150 renal transplants per year; of these, it was conservatively estimated that approximately 30% of these patients would be have diabetes, eligible, and willing to participate in this study. Thus, approximately 45 patients per year would be the expected accrual annual rate. This rate for a projected accrual period of 27 months would be expected to yield approximately 90 participants in the trial. Using the feasible sample size of 90 participants, there was 80% power to detect an effect size of 0.48 for the secondary outcomes (i.e. a 0.48‐SD difference in continuous outcomes)" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow‐up for at least 2 weeks (interim analysis): 51</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard glycaemic control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>104</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>89</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: strict blood glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>223*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 81*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: liberal blood glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>81*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>81*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>81*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: aggressive glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 82</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: moderate glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="right" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>82</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>82</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>82</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"The minimum required sample size was determined by using an appropriate formula that would provide 80% power to detect a 16% difference in the postoperative complication rate at a 0.05 level (two sided test)" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 28 days: 179</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>179</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>179</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>179</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a> </p> <p>Parallel‐group RCT</p> <p>Study terminated early</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 28 days: 124*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: intermediate glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign="top"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>124*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>124*</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>213*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>213*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>203*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 90 days: 402*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>208*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>208*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>199*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>421*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>421*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>402*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>95</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a> </p> <p>Parallel‐group RCT</p> <p>Study terminated early</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: continuous insulin infusion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 126</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard intermittent insulin bolus</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign="top"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>126</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>126</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a><sup>a</sup> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive Insulin treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 32*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional insulin treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>32*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>32*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>32*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 28 days: 13*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100*</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>13*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>13*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>13*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100*</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 73</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>78</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>73</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>73</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>94</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a><sup>b</sup> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: continuous insulin infusion (CII)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: glucometer‐guided insulin (GGI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: tight glycaemic control with GIK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 141</p> <p>Follow up 5 years: 120</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>141</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>141</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>141</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: aggressive insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"Using published data, we determined that group sizes of 13 patients per study group would give us 84% power to detect a significant (20%) increase in Polymorphonuclear neutrophils function in the treatment groups after surgery at a 5% level of significance" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>26</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>26</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>26</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Grand total</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>All interventions</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1320</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1316</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>All comparators</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1350</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1333</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>All interventions and comparators</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>2670</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>2649</b> </p> </th> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p><sup>a</sup>From the total population 11 participants withdrew from both groups after randomisation.<br/><sup>b</sup>Seven participants in the control group dropped out of the study after surgery and were switched to the intervention regimen because their personal surgeon considered their degree of blood glucose control to be unacceptable. </p> <p>Number of randomised participants in <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a> and <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a> not available; ITT population used instead. </p> <p>*Data provided by study authors.</p> <p>—: not reported</p> <p><b>C</b> : control group; <b>GIK</b> : glucose‐insulin‐potassium; <b>I</b> : intervention group; <b>ITT</b> : intention‐to‐treat: <b>RCT</b>: randomised controlled trial. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of study population (participants with diabetes undergoing surgery)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007315-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overview of study population (total participants of studies)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study (design)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention(s) and comparator(s)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Description of power and sample size calculation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Screened/eligible (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Randomised (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Analysed (primary outcome) (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Finishing trial (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Randomised finishing trial (%)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Follow‐up</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0006" title="DuncanAE , DanielI , SesslerMD , HiroakiS , SatoT , KeisukeN , et al. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications. A randomized clinical trial. Anesthesiology2018;128:1125-39. NCT00524472. Outcomes study of hyperinsulinemic glucose control in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00524472 (first received 3 September 2007). SaagerL , DuncanAE , YaredJP , HeslerBD , YouJ , DeogaonkarA , et al. Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery. Anesthesiology2015;122(6):1214-23. SchrickerT , SatoH , BeaudryT , CodereT , HatzakorzianR , PruessnerJC . Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PloS One2014;9(6):e99661. [DOI: https://doi.org/10.1371/journal.pone.0099661]">Duncan 2018</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: hyperinsulinaemic normoglycaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"A maximum of 2,790 patients was required to detect a 30% relative reduction in the composite of any major complications (i.e., any vs. none) from an expected 15% incidence of complications in the standard group at the overall 0.05 significance level with 90% power" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days:</p> <p>1439</p> <p>Follow up 1 year: 1335</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>730</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>730</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>730</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1439</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1439</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1439</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0019" title="NCT01211730. Study of glycemic control on liver transplantation outcomes. clinicaltrials.gov/ct2/show/NCT01211730 (first received 29 September 2010). WalliaA , SchmidtK , OakesDJ , PollackT , WelshN , Kling-ColsonS , et al. Glycemic control reduces infections in post–liver transplant patients: results of a prospective, randomized study. Journal of clinical Endocrinology and Metabolism2017;102:451–9. [DOI: 10.1210/jc.2016-3279]">Wallia 2017</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive (140 group)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"Based on our cross‐sectional analyses, the 1‐year rejection rate in the 140‐mg/dL group was assumed to be 20% and in the 180‐mg/dL group was assumed to be 44%. Using these rates, we estimated that a total sample size of 136 patients, 68 in each group, would give us 80% power (a = 0.05, 2‐sided) to detect a statistically significant difference between these groups. We estimated a potential withdrawal rate of 20%, giving a total of 82 patients in each group, for a total of 164 patients to be randomized" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>733</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>1 year follow‐up: 164</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: moderate (180 group)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>164</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>164</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>164</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0018" title="WahbyEA , Abo ElnasrMM , EissaMI , MahmoudSM . Perioperative glycemic control in diabetic patients undergoingcoronary artery bypass graft surgery. Journal of the Egyptian Society of Cardio-Thoracic Surgery2016;24:143-9. [DOI: https://doi.org/10.1016/j.jescts.2016.05.007]">Wahby 2016</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: tight glycaemic control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 days follow‐up: 67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional moderate glycaemic control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 days follow‐up: 68</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>135</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>135</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>135</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0014" title="NCT01643382. Hyperglycemia in renal transplantation (HiRT). clinicaltrials.gov/ct2/show/NCT01643382 (first received 18 July 2012). ParekhJ , RollGR , WiselS , RushakoffR , HiroseR . EEffect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clinical Transplantation2016;30:1242-9. ">Parekh 2016</a> </p> <p>Parallel‐group RCT</p> <p>Study terminated early</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: moderately intense control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"With a power of 80% and P‐value of.05, we estimated a needed sample size of 40 recipients per study group" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>327 (69)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Follow up 30 days: 58</p> <p>Follow up 6 months: 51</p> <p>Follow up 1 year: 42</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>60</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>60</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>60</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0020" title="YuanJ , LiuT , ZhangX , SiY , YeY , ZhaoC , et al. Intensive versus conventional glycemic control in patients with diabetes during enteral nutrition after gastrectomy. Journal of Gastrointestinal Surgery2015;19:1553-8. [DOI: 10.1007/s11605-015-2871-7]">Yuan 2015</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive glycaemic (IG) management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional glycaemic (CG) management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>212</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>212</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>210</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>99</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0017" title="NCT01361594. Intensive insulin therapy in patients undergoing coronary artery bypass surgery (CABG). clinicaltrials.gov/ct2/show/NCT01361594 (first received 31 December 2014). UmpierrezG , CardonaS , PasquelF , JacobsS , PengL , UnigweM , et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary arterybypass graft surgery: GLUCO-CABG trial. Diabetes Care2015;38(9):1665–72. [DOI: 10.2337/dc15-0303]">Umpierrez 2015</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"Sample size was based on previous studies by van den Berghe et al. and Umpierrez et al. We estimated an incidence rate of the primary end point in the control group of 20% and odds ratio for the intensive versus conservative glucose control group of 0.35. We expected a low attrition rate of, 10% in the ICU; using two sided Fisher exact test, with a = 0.05, we estimated that the sample size required for 80% power to be 148 patients per group (a total of 296 patients) for the primary end point. For all analyses, reported P values are two‐sided, and P values 0.05 were considered significant. All analyses were performed using SAS software version 9.2 (SAS Institute, Cary, NC)" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>855</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Follow‐up 90 days after discharge</p> <p>151</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conservative group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>305</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>302</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>302</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>99</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0001" title="AbdelmalakBB , Bonilla, MaschaEJ , MaheshwariA , TangWH , YouMJ , et al. Dexamethasone, light anaesthesia, and tight glucose control(DeLiT) randomized controlled trial. British Journal of Anaesthesia2013;111(2):209-21. NCT00433251. The effects of corticosteroids, glucose control, and depth-of-anaesthesia on perioperative inflammation and morbidity form major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00433251 (first received 15 October 2009). NCT00995501. The effects of coroticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery (dexamethasone, light anesthesia and tight glucose control (DeLiT Trial)). clinicaltrials.gov/ct2/show/NCT00995501 (first received 15 October 2009). ">Abdelmalak 2013</a> </p> <p>Parallel‐group RCT</p> <p>Study terminated early</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive glucose management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"A maximum of 970 total patients were required to have 90% power at the 0.05 significance level to detect a 40% relative reduction on the primary outcome for the most effective intervention (whichever of the three), assuming effects of 20% and 10% for the other two interventions. If only one of the three factors had any effect, we had 90% power to detect a slightly narrower 37% relative reduction" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Follow up 30 days: 381</p> <p>Follow up 1 year: 381</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional glucose management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>381</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>381</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>381</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0009" title="HermayerKL , EgidiMF , FinchNJ , BaligaP , LinA , KettingerL , et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. Journal of Clinical Endocrinology and Metabolism2012;97:4399–406. ">Hermayer 2012</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive glycaemic control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"The statistical error rates were established a priori at 0.15 and 0.20 for the type I and type II error rates, respectively. The sample size for the clinical trial was based on feasibility of enrollment along with power to detect a clinically relevant effect size in secondary endpoints (e.g. BG levels and biomarkers) at the P 0.15 level of significance. The upper bound for the recruitment potential of this single clinical site was based on transplant volume. The transplant center estimated approximately 150 renal transplants per year; of these, it was conservatively estimated that approximately 30% of these patients would have diabetes, eligible, and willing to participate in this study. Thus, approximately 45 patients per year would be the expected accrual annual rate. This rate for a projected accrual period of 27 months would be expected to yield approximately 90 participants in the trial. Using the feasible sample size of 90 participants, there was 80% power to detect an effect size of 0.48 for the secondary outcomes (i.e. a 0.48‐SD difference in continuous outcomes)" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Follow‐up for at least 2 weeks (interim analysis): 51</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard glycaemic control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>104</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>89</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0005" title="DesaiSP , HenryLL , HolmesSD , HuntSL , MartinCT , HebsurS , et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery2012;143(2):318-25. PezzellaAT , HolmesSD , PritchardG , SpeirAM , AdN . Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annals of Thoracic Surgery2014;98:1281-5. [DOI: 10.1016/j.athoracsur.2014.05.067] [PMID: 25134860]">Desai 2012</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: strict blood glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"The a priori sample size of this study (N=200) was determined to be sufficient using a medium effect size, an alpha level of 0.05, and 80% power.20 Observed power was found to be robust for significant results, but not robust for nonsignificant results as expected, given the much smaller observed effect sizes for those comparisons" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>223</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 189</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: liberal blood glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>189</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>189</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>189</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0011" title="LazarHL , McDonnellMM , ChipkinS , FitzgeraldC , BlissC , CabralH . Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of Surgery2011;254(3):458-64. [NCT00460499]NCT00460499. Improving outcomes in diabetic patients during CABG surgery by omptimizing glycemic control. clinicaltrials.gov/ct2/show/NCT00460499 (first received 16 April 2007). ">Lazar 2011</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: aggressive glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 82</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: moderate glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="right" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>82</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>82</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>82</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>82</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0002" title="CaoSG , RenJA , ShenB , ChenD , ZhouYB , LiJS . Intensive versus conventional insulin in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World Journal of Surgery2011;35(1):85-92. ">Cao 2010</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"The minimum required sample size was determined by using an appropriate formula that would provide 80% power to detect a 16% difference in the postoperative complication rate at a 0.05 level (two‐sided test)" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 28 days: 179</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>179</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>179</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>179</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a> </p> <p>Parallel‐group RCT</p> <p>Study terminated early</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"The power of the sample size of 1,078 patients to detect a 4% difference in ICU mortality with an alpha error rate of 5% and beta error rate of 20% was 32%. </p> <p>The expected mortality in the ‘‘control’’ group (group 1) was based on the data recorded in the preliminary survey and was used to calculate the sample size needed to detect a 4% decrease in mortality with an alpha error rate of 5% and beta error rate of 20% (n = 1,496 patients in each group). A total of 1,750 patients per group were deemed necessary to account for drop‐outs" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>7747</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>536</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>536</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 28 days: 1078</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: intermediate glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>551</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>542</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>542</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1101</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1078</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>1078</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>98</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0013" title="FinferS , ChittockDR , SuSY , BlairD , FosterD , DhingraV , et al, NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine2009;360(13):1283-97. NCT00220987. Normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR STUDY). clinicaltrials.gov/ct2/show/NCT00220987 (first received 22 September 2005). ">NICE SUGAR 2009</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"The study was originally designed to enroll 4000 patients. On the basis of data reported by Van den Berghe et al. in 2006, 13 the sample size was increased to 6100, thereby providing a statistical power of 90% to detect an absolute difference in mortality between the two groups of 3.8 percentage points, assuming a baseline mortality of 30% at a two‐sided alpha level of less than 0.05" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>40,171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3054</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3054</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>90 days follow‐up</p> <p>6022</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional glucose control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3050</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3050</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>6104</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>6104</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>6022</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>99</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a> </p> <p>Parallel‐group RCT</p> <p>Study terminated early</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: continuous insulin infusion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"A conservative estimate of 5% rate of MACEs in patients undergoing vascular surgery was assumed for the current study. Assuming a 10% dropout rate, this study needed 993 patients in each group to show a 50% reduction in MACEs for 80% (1‐Beta) power and a statistical significance of P 0.05 (alfa) in patients receiving continuous intravenous insulin infusion compared with conventional therapy. An interim analysis was planned at 452 patients" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 236</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard intermittent insulin bolus</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>242</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>236</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>236</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>98</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0003" title="ChanRP , GalasFR , HajjarLA , BelloCN , PiccioniMA , Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo)2009;64(1):51-60. NCT00370643. Glucose control in open heart surgery. clinicaltrials.gov/ct2/show/NCT00370643 (first received 1 September 2006). ">Chan 2009</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive Insulin treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow‐up 30 days: 98</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional insulin treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>109</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>109</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>98</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>90</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0004" title="De La RosaGC , DonadoJH , RestrepoAH , QuinteroAM , GonzálezLG , SaldarriagaNE , et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care2008;12(5):R120. ">De La Rosa 2008</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"We estimated that the enrollment of 504 patients would provide a power of 80% to detect an absolute reduction of 10% in the 28‐day mortality rate with an alpha error (two‐sided test) of 0.05. We assumed a 25% mortality rate in the control group" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1643</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 28 days: 502</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>504</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>504</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>502</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>99</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0007" title="GandhiGY , NuttallGA , AbelM , MullanyCJ , SchaffHV , O'BrienPC , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Annals of Internal Medicine2007;146(4):233-43. NCT00282698. Outcomes with tight control of hyperglycemia in cardiac surgery patients. clinicaltrials.gov/ct2/show/NCT00282698 (first received 27 January 2006). ">Gandhi 2007</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"On the basis of a composite outcome rate of 40% in the conventional treatment group. We needed to enroll 177 patients per treatment group to have 90% power (2‐sided " level of 0.05) of finding a 40% decrease in the composite outcome with intensive insulin therapy (decrease from 40% to 24%). Because we expected that approximately 10% of patients would not experience hyperglycemia during surgery, we randomly assigned 200 patients per treatment group to ensure a sufficient number with outcome information" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>502</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 371</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: conventional treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>400</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>379</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>371</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0012" title="LiJY , SunS , WuSJ . Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal2006;33(4):445-51. ">Li 2006</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: continuous insulin infusion (CII)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: glucometer‐guided insulin (GGI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>93</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0010" title="LazarHL , ChipkinSR , FitzgeraldCA , BaoY , CabralH , ApsteinCS . Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004;109(12):1497-502. ">Lazar 2004</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: tight glycaemic control with GIK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Follow up 30 days: 141</p> <p>Follow up 5 years: 120</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>141</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>141</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>141</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007315-bbs2-0015" title="RassiasAJ , MarrinCAS , ArrudaJ , WhalenPK , BeachM , YeagerMP . Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia1999;88(5):1011-6. ">Rassias 1999</a> </p> <p>Parallel‐group RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: intensive insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"Using published data, we determined that group sizes of 13 patients per study group would give us 84% power to detect a significant (20%) increase in Polymorphonuclear neutrophils function in the treatment groups after surgery at a 5% level of significance" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: standard insulin therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <th align="right" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Total:</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>26</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>26</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>26</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>100</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Grand total</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>All interventions</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>5981</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>5887</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>All comparators</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>5996</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>5914</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>All interventions and comparators</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>11,977</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>11,801</b> </p> </th> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>Number of randomised participants in <a href="./references#CD007315-bbs2-0008" title="NCT00107601. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. clinicaltrials.gov/ct2/show/NCT00107601 (first received 6 April 2005). PenningS , ChaseJG , PreiserJC , PrettyCG , SignalM , MelotC , et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? a post hoc analysis of the glucontrol trial. Journal of Critical Care2014;29(3):374-9. [DOI: 10.1016/j.jcrc.2014.01.013]Preiser J-C, DevosP , Ruiz-SantanaS , MélotC , AnnaneD , GroeneveldJ , et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine2009;35(10):1738-48. ">Glucontrol 2009</a> and <a href="./references#CD007315-bbs2-0016" title="SubramaniamB , PanzicaPJ , NovackV , MahmoodF , MatyalR , MitchellJD , et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology2009;110(5):970-7. ">Subramaniam 2009</a> not available; ITT population used instead. </p> <p>*Data provided by study authors.</p> <p>—: not reported</p> <p><b>C</b> : control group; <b>GIK</b> : glucose‐insulin‐potassium; <b>I</b> : intervention group; <b>ITT</b> : intention‐to‐treat; <b>RCT</b>: randomised controlled trial. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overview of study population (total participants of studies)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/full#CD007315-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007315-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Perioperative intensive vs conventional glycaemic control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2551</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.88, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 All‐cause mortality (sensitivity analysis: only published data; low risk of bias) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Only published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>820</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.34, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1421</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.88, 1.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Hypoglycaemic episodes (severe) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.73 [2.12, 10.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Hypoglycaemic episodes (any) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2410</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.36 [1.69, 6.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Hypoglycaemic episodes (severe; sensitivity analysis: only published data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.59 [0.05, 52.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Hypoglycaemic episodes (any; sensitivity analysis: only published data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>834</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.24 [0.56, 8.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Infectious complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2453</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.55, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Infectious complications (sensitivity analysis: only published data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.38, 0.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Cardiovascular events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1454</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.55, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Cardiovascular events (sensitivity analysis: only published data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>727</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.50, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Renal failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2086</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.69, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Renal failure (sensitivity analysis: only published data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.42, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Length of ICU stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1687</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.57, 0.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Length of ICU stay (sensitivity analysis: only published data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [‐0.07, 0.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1520</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.79 [‐1.79, 0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.16 Length of hospital stay (sensitivity analysis: only published data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.09 [‐1.82, ‐0.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Perioperative intensive vs conventional glycaemic control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007315.pub3/references#CD007315-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007315.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD007315-note-0009">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD007315-note-0019">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007315-note-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007315-note-0018">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD007315-note-0015">Hrvatski</a> </li> <li class="section-language"> <a class="" href="id#CD007315-note-0017">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="ja#CD007315-note-0014">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD007315-note-0013">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD007315-note-0011">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD007315-note-0012">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD007315-note-0010">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007315\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007315\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007315\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007315\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007315\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007315\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007315\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007315\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007315\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007315\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007315\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007315\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007315\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007315\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007315\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007315\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007315\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007315\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WcPhDegp&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007315.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007315.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007315.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007315.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007315.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726458432"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007315.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726458436"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007315.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e941ece389368',t:'MTc0MDcyNjQ1OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 